1
|
Sánchez Díaz M, Flórez Á, Carretero-Hernández G, Grau-Pérez M, García-Doval I, Carrascosa-Carrillo JM. Study of the impact of restrictions on access to biological drugs for the management of psoriasis on the Minimum Disease Activity criteria: subanalysis of AEDV EQUIDAD and AME projects. Actas Dermosifiliogr 2024:S0001-7310(24)00415-0. [PMID: 38768808 DOI: 10.1016/j.ad.2024.02.033] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2023] [Revised: 12/05/2023] [Accepted: 02/06/2024] [Indexed: 05/22/2024] Open
Abstract
Spanish Autonomous Communities (ACs) are entitled to decide on the prescription requirements of their own territories, which can create inequalities in access to new drugs in the management of psoriasis. The objective of this study was to assess whether the level of restrictions in the access to new drugs for the management psoriasis was associated with the probability of achieving disease control measured using the Minimum Disease Activity (MDA) criteria. Therefore, we combined the results of 2 previous independent, cross-sectional studies: one that described the MDA in psoriasis by AC, and another that evaluated the level of restrictions to drug access by AC. We found that the higher the number of restrictions the lower the chances of achieving the MDA criteria (p = 0.013). Our results suggest that, in Spain, geographical differences in the access to new drugs may be creating health inequalities across the country.
Collapse
Affiliation(s)
- M Sánchez Díaz
- Becario Juan de Azúa, Unidad de Investigación. Fundación Piel Sana de la Academia Española de Dermatología y Venereología, Madrid, Spain; Servicio de Dermatología. Hospital Universitario Virgen de las Nieves Instituto de Investigación Biosanitaria IBS, Granada, Spain
| | - Á Flórez
- Servicio de Dermatología, Complejo Hospitalario Universitario de Pontevedra, Grupo de Investigación DIPO, IIS Galicia Sur-SERGAS-UVIGO, Pontevedra, Spain
| | - G Carretero-Hernández
- Servicio de Dermatología. Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain
| | - M Grau-Pérez
- Servicio de Dermatología. Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain; Unidad de Investigación. Fundación Piel Sana de la Academia Española de Dermatología y Venereología, Madrid, Spain
| | - I García-Doval
- Unidad de Investigación. Fundación Piel Sana de la Academia Española de Dermatología y Venereología, Madrid, Spain; Servicio de Dermatología. Hospital do Meixoeiro, Vigo, Spain.
| | | |
Collapse
|
2
|
Verdaguer-Faja J, Borrego L, Mercader-García P, González Pérez R, Córdoba-Guijarro S, Giménez-Arnau AM, Ruiz-González I, Miquel-Miquel J, Francisco Silvestre J, Ortiz de Frutos FJ, Tous-Romero F, Sanz Sánchez T, Rodríguez-Serna M, Sánchez-Pérez J, Serra Baldrich E, Zaragoza-Ninet V, Pastor-Nieto MA, Gatica-Ortega ME, Sánchez Gilo A, Melé-Ninot G, Sánchez-Pedreño Guillén P, Munera-Campos M, Descalzo MÁ, García-Doval I, Carrascosa JM. [[Translated article]]Epidemiological, Clinical, and Allergic Profile of Psoriatic Patients. Evaluation of the Spanish Registry of Contact Dermatitis and Cutaneous Allergy (REIDAC). Actas Dermosifiliogr 2024:S0001-7310(24)00353-3. [PMID: 38648935 DOI: 10.1016/j.ad.2024.04.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2023] [Accepted: 02/06/2024] [Indexed: 04/25/2024] Open
Abstract
BACKGROUND Psoriasis is a chronic inflammatory dermatosis whose clinical and topographic distribution requires differential diagnosis, or the possible association with allergic contact dermatitis (ACD), requiring patch testing (PT) as part of the diagnostic procedure. OBJECTIVES To describe the epidemiological, clinical, and allergic profile of patients with a primary or secondary diagnosis of psoriasis undergoing PT and compare them with patients with a diagnosis of ACD at the end of the diagnostic process. METHODS Cross-sectional study with data from REIDAC from 2018 through 2023 of selected patients with a diagnosis of psoriasis and/or ACD. RESULTS A total of 11 502 patients were included, 513 of whom had been diagnosed with primary or secondary psoriasis, 3640 with ACD, and 108 with both diseases. Men were more predominant in the groups of patients with psoriasis, psoriasis + ACD, and lesions were more predominantly seen in the hands with little association with atopic factors vs the ACD group. The rate of positivity in PT to the 2022 Spanish battery of allergens was lower in the group with psoriasis only in 27% of the patients. The most common allergens found in the psoriasis group were also the most common ones found in the overall ACD population. CONCLUSIONS Overall, 36.2% of psoriatic patients tested positive in PT to the 2022 Spanish battery of allergens, which proved that this association is not uncommon. Overall, psoriatic patients had a higher mean age, were more predominantly men, and showed more hand involvement.
Collapse
Affiliation(s)
- J Verdaguer-Faja
- Servicio de Dermatología del Hospital Universitari Germans Trias i Pujol, Spain.
| | - L Borrego
- Servicio de Dermatología del Complejo Hospitalario Universitario Insular. Universidad de Las Palmas de Gran Canaria, Spain
| | - P Mercader-García
- Servicio de Dermatología del Hospital General Universitario Morales Meseguer, Spain
| | - R González Pérez
- Hospital Universitario De Araba, Universidad del país vasco, Spain
| | | | - A M Giménez-Arnau
- Hospital del Mar. Research Institute. Universitat Pompeu Fabra, Spain
| | | | | | | | | | | | | | | | | | | | | | | | | | | | - Gemma Melé-Ninot
- Hospital Universitari Sagrat Cor, Grupo Quirónsalud, Barcelona, Spain
| | | | - M Munera-Campos
- Servicio de Dermatología del Hospital Universitari Germans Trias i Pujol, Spain
| | - M Á Descalzo
- Unidad de Investigación. Fundacion Piel Sana, Spain
| | | | - J M Carrascosa
- Servicio de Dermatología del Hospital Universitari Germans Trias i Pujol, Spain; Universitat Autònoma de Barcelona. UAB. IGTP, Spain
| |
Collapse
|
3
|
Couselo-Rodríguez C, Batalla A, Carrascosa JM, Chicharro P, González-Quesada A, de la Cueva P, Giménez-Arnau AM, Gilaberte Y, Rodríguez-Serna M, Montero-Vilchez T, Ruiz-Villaverde R, Elosua-González M, Silvestre-Salvador JF, Munera-Campos M, Sánchez-Pérez J, Carretero G, Mauleón-Fernández C, Curto-Barredo L, Ballano-Ruiz A, Botella-Estrada R, Arias-Santiago S, Navarro-Triviño FJ, Roustan-Gullón G, Betlloch I, Del Alcázar E, Abalde-Pintos MT, Suárez-Perez J, García-Doval I, Descalzo MÁ, Flórez Á. [Translated article] Drug Survival in Cyclosporine Treatment for Moderate to Severe Atopic Dermatitis: Analysis of the Spanish Atopic Dermatitis Registry (BIOBADATOP). Actas Dermosifiliogr 2024; 115:T341-T346. [PMID: 38325545 DOI: 10.1016/j.ad.2023.07.028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2023] [Accepted: 07/03/2023] [Indexed: 02/09/2024] Open
Abstract
BACKGROUND The past 5 years have seen a proliferation of new treatments for atopic dermatitis (AD). We analyzed recent drug survival data for cyclosporine in this setting. Because the Spanish National Healthcare system requires patients with AD to be treated with cyclosporine before they can be prescribed other systemic treatments, drug survival for cyclosporine may be shorter than in other diseases. MATERIAL AND METHOD Multicenter, observational, prospective cohort study using data from the Spanish Atopic Dermatitis Registry (BIOBADATOP). Data from the Spanish Registry of Systemic Treatments in Psoriasis (BIOBADADERM) were used to create a comparison cohort. RESULTS We analyzed data for 130 patients with AD treated with cyclosporine (median drug survival, 1 year). Median cyclosporine survival in the psoriasis comparison group (150 patients) was 0.37 years. Drug survival was significantly longer in AD than in psoriasis (P<.001). CONCLUSION Drug survival of cyclosporine in the BIOBADATOP registry is similar to that described in other series of patients with AD and longer than that observed in the BIOBADADERM psoriasis registry.
Collapse
Affiliation(s)
- C Couselo-Rodríguez
- Servicio de Dermatología, Complejo Hospitalario Universitario de Pontevedra, Pontevedra, Spain; Grupo de Investigación DIPO, Instituto de Investigación Sanitaria Galicia Sur (IIS Galicia Sur), SERGAS-UVIGO, Spain.
| | - A Batalla
- Servicio de Dermatología, Complejo Hospitalario Universitario de Pontevedra, Pontevedra, Spain; Grupo de Investigación DIPO, Instituto de Investigación Sanitaria Galicia Sur (IIS Galicia Sur), SERGAS-UVIGO, Spain
| | - J M Carrascosa
- Servicio de Dermatología, Hospital Universitari Germans Trias i Pujol. Germans Trias I Pujol Research Institute (IGTP), Universitat Autònoma de Barcelona, Badalona, Barcelona, Spain
| | - P Chicharro
- Servicio de Dermatología, Hospital Universitario de la Princesa, Madrid, Spain
| | - A González-Quesada
- Servicio de Dermatología, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain
| | - P de la Cueva
- Servicio de Dermatología, Hospital Universitario Infanta Leonor, Madrid, Spain
| | - A M Giménez-Arnau
- Servicio de Dermatología, Hospital del Mar, IMIM, Universitat Pompeu Fabra, Barcelona, Spain
| | - Y Gilaberte
- Servicio de Dermatología, Hospital Universitario Miguel Servet, Zaragoza, Spain
| | - M Rodríguez-Serna
- Servicio de Dermatología, Hospital Universitario y Politécnico la Fe, Valencia, Spain
| | - T Montero-Vilchez
- Servicio de Dermatología, Hospital Universitario Virgen de las Nieves, Granada. Instituto de Investigación IBS, Granada, Spain
| | - R Ruiz-Villaverde
- Servicio de Dermatología, Hospital Universitario San Cecilio, Granada, Spain
| | - M Elosua-González
- Servicio de Dermatología, Hospital Universitario Puerta del Hierro, Madrid, Spain
| | - J F Silvestre-Salvador
- Servicio de Dermatología, Hospital General Universitario Dr. Balmis, Alicante. ISABIAL, Alicante, Spain
| | - M Munera-Campos
- Servicio de Dermatología, Hospital Universitari Germans Trias i Pujol. Germans Trias I Pujol Research Institute (IGTP), Universitat Autònoma de Barcelona, Badalona, Barcelona, Spain
| | - J Sánchez-Pérez
- Servicio de Dermatología, Hospital Universitario de la Princesa, Madrid, Spain
| | - G Carretero
- Servicio de Dermatología, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain
| | - C Mauleón-Fernández
- Servicio de Dermatología, Hospital Universitario Infanta Leonor, Madrid, Spain
| | - L Curto-Barredo
- Servicio de Dermatología, Hospital del Mar, IMIM, Universitat Pompeu Fabra, Barcelona, Spain
| | - A Ballano-Ruiz
- Servicio de Dermatología, Hospital Universitario Miguel Servet, Zaragoza, Spain
| | - R Botella-Estrada
- Servicio de Dermatología, Hospital Universitario y Politécnico la Fe, Valencia, Spain
| | - S Arias-Santiago
- Servicio de Dermatología, Hospital Universitario Virgen de las Nieves, Granada. Instituto de Investigación IBS, Granada, Spain
| | - F J Navarro-Triviño
- Servicio de Dermatología, Hospital Universitario San Cecilio, Granada, Spain
| | - G Roustan-Gullón
- Servicio de Dermatología, Hospital Universitario Puerta del Hierro, Madrid, Spain
| | - I Betlloch
- Servicio de Dermatología, Hospital General Universitario Dr. Balmis, Alicante. ISABIAL, Alicante, Spain
| | - E Del Alcázar
- Servicio de Dermatología, Hospital Universitari Germans Trias i Pujol. Germans Trias I Pujol Research Institute (IGTP), Universitat Autònoma de Barcelona, Badalona, Barcelona, Spain
| | - M T Abalde-Pintos
- Servicio de Dermatología, Complejo Hospitalario Universitario de Pontevedra, Pontevedra, Spain; Grupo de Investigación DIPO, Instituto de Investigación Sanitaria Galicia Sur (IIS Galicia Sur), SERGAS-UVIGO, Spain
| | - J Suárez-Perez
- Servicio de Dermatología, Hospital Clínico de Málaga, Málaga, Spain
| | - I García-Doval
- Unidad de Investigación, Fundación Piel Sana AEDV, Spain; Servicio de Dermatología, Complexo Hospitalario Universitario de Vigo, Vigo, Spain
| | - M Á Descalzo
- Unidad de Investigación, Fundación Piel Sana AEDV, Spain
| | - Á Flórez
- Servicio de Dermatología, Complejo Hospitalario Universitario de Pontevedra, Pontevedra, Spain; Grupo de Investigación DIPO, Instituto de Investigación Sanitaria Galicia Sur (IIS Galicia Sur), SERGAS-UVIGO, Spain
| |
Collapse
|
4
|
Tous-Romero F, Borrego-Hernando L, García-Doval I, Mercader-García P, Silvester-Salvador JF, Sánchez-Gilo A, Sanz-Sánchez T, Giménez-Arnau AM, Zaragoza-Ninet V, Miquel-Miquel J, González Pérez R, Córdoba-Guijarro S, Carrascosa-Carrillo JM, Gática-Ortega ME, Ruíz-González I, Serra-Baldrich E, Pastor-Nieto A, Rodríguez-Serna M, Sánchez-Pérez J, Melé I Ninot G, Sánchez-Pedreño Guillén P, Ortiz-de Frutos J. Four-year Epidemiological Surveillance of the Spanish Registry of Research in Contact Dermatitis and Cutaneous Allergy: Current Situation and Trends. Actas Dermosifiliogr 2024; 115:331-340. [PMID: 38061453 DOI: 10.1016/j.ad.2023.10.039] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2023] [Revised: 10/25/2023] [Accepted: 10/31/2023] [Indexed: 12/29/2023] Open
Abstract
BACKGROUND The epidemiological surveillance of contact dermatitis is one of the objectives of the Spanish Registry of Research in Contact Dermatitis and Cutaneous Allergy. Knowing whether the prevalence of positive tests to the different allergens changes over time is important for this monitoring process. OBJECTIVES To describe the various temporary trends in allergen positivity in the GEIDAC standard series from 2018 through December 31, 2022. METHODS This was a multicenter, observational trial of consecutive patients analyzed via patch tests as part of the study of possible allergic contact dermatitises collected prospectively within the Spanish Registry of Research in Contact Dermatitis and Cutaneous Allergy. The data was analyzed using 2 statistical tests: one homogeneity test (to describe the changes seen over time) and one trend test (to see whether the changes described followed a linear trend). RESULTS A total of 11327 patients were included in the study. Overall, the allergens associated with a highest sensitization were nickel sulfate, methylisothiazolinone, cobalt chloride, methylchloroisothiazolinone/methylisothiazolinone, and fragrance mix i. A statistically significant decrease was found in the percentage of methylisothiazolinone positive tests across the study years with an orderly trend. CONCLUSIONS Although various changes were seen in the sensitizations trends to several allergens of the standard testing, it became obvious that a high sensitization to nickel, methylchloroisothiazolinone/methylisothiazolinone and fragrances mix i remained. Only a significant downward trend was seen for methylisothiazolinone.
Collapse
Affiliation(s)
- F Tous-Romero
- Servicio de Dermatología, Hospital Universitario 12 de Octubre, Madrid, España.
| | - L Borrego-Hernando
- Servicio de Dermatología, Hospital Universitario Insular de Gran Canaria, Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Las Palmas, España
| | - I García-Doval
- Unidad de Investigación, Fundación Piel Sana AEDV, Madrid, España
| | - P Mercader-García
- Servicio de Dermatología, Hospital General Universitario José M. Morales Meseguer, Murcia, España
| | | | - A Sánchez-Gilo
- Servicio de Dermatología, Hospital Rey Juan Carlos, Madrid, España
| | - T Sanz-Sánchez
- Servicio de Dermatología, Hospital Universitario Infanta Sofía, Madrid, España
| | | | - V Zaragoza-Ninet
- Servicio de Dermatología, Hospital Universitario de Valencia, Valencia, España
| | - J Miquel-Miquel
- Servicio de Dermatología, Hospital Universitario Arnau de Vilanova, Valencia, España
| | - R González Pérez
- Servicio de Dermatología, Hospital Universitario Araba, Vitoria, Álava, España
| | - S Córdoba-Guijarro
- Servicio de Dermatología, Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, España
| | - J M Carrascosa-Carrillo
- Servicio de Dermatología, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, España
| | - M E Gática-Ortega
- Servicio de Dermatología, Complejo Hospitalario Universitario de Toledo, Toledo, España
| | - I Ruíz-González
- Servicio de Dermatología, Complejo Asistencial Universitario de León, León, España
| | - E Serra-Baldrich
- Servicio de Dermatología, Hospital de la Santa Creu i San Pau, Barcelona, España
| | - A Pastor-Nieto
- Servicio de Dermatología, Hospital Fundación Jiménez Díaz, Madrid, España
| | - M Rodríguez-Serna
- Servicio de Dermatología, Hospital Universitario La Fe, Valencia, España
| | - J Sánchez-Pérez
- Servicio de Dermatología, Hospital Universitario de La Princesa, Madrid, España
| | - G Melé I Ninot
- Servicio de Dermatología, Hospital Sagrat Cor, Barcelona, España
| | | | - J Ortiz-de Frutos
- Servicio de Dermatología, Hospital Universitario 12 de Octubre, Madrid, España
| |
Collapse
|
5
|
Couselo-Rodríguez C, Batalla A, Carrascosa JM, Chicharro P, González-Quesada A, de la Cueva P, Giménez-Arnau AM, Gilaberte Y, Rodríguez-Serna M, Montero-Vilchez T, Ruiz-Villaverde R, Elosua-González M, Silvestre-Salvador JF, Munera-Campos M, Sánchez-Pérez J, Carretero G, Mauleón-Fernández C, Curto-Barredo L, Ballano-Ruiz A, Botella-Estrada R, Arias-Santiago S, Navarro-Triviño FJ, Roustan-Gullón G, Betlloch I, Del Alcázar E, Abalde-Pintos MT, Suárez-Perez J, García-Doval I, Descalzo MÁ, Flórez Á. Drug Survival in Cyclosporine Treatment for Moderate to Severe Atopic Dermatitis: Analysis of the Spanish Atopic Dermatitis Registry (BIOBADATOP). Actas Dermosifiliogr 2024; 115:341-346. [PMID: 37482292 DOI: 10.1016/j.ad.2023.07.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2023] [Revised: 06/04/2023] [Accepted: 07/03/2023] [Indexed: 07/25/2023] Open
Abstract
BACKGROUND The past 5 years have seen a proliferation of new treatments for atopic dermatitis (AD). We analyzed recent drug survival data for cyclosporine in this setting. Because the Spanish National Healthcare system requires patients with AD to be treated with cyclosporine before they can be prescribed other systemic treatments, drug survival for cyclosporine may be shorter than in other diseases. MATERIAL AND METHOD Multicenter, observational, prospective cohort study using data from the Spanish Atopic Dermatitis Registry (BIOBADATOP). Data from the Spanish Registry of Systemic Treatments in Psoriasis (BIOBADADERM) were used to create a comparison cohort. RESULTS We analyzed data for 130 patients with AD treated with cyclosporine (median drug survival, 1 year). Median cyclosporine survival in the psoriasis comparison group (150 patients) was 0.37 years. Drug survival was significantly longer in AD than in psoriasis (P<.001). CONCLUSION Drug survival of cyclosporine in the BIOBADATOP registry is similar to that described in other series of patients with AD and longer than that observed in the BIOBADADERM psoriasis registry.
Collapse
Affiliation(s)
- C Couselo-Rodríguez
- Servicio de Dermatología, Complejo Hospitalario Universitario de Pontevedra, Pontevedra, España; Grupo de Investigación DIPO, Instituto de Investigación Sanitaria Galicia Sur (IIS Galicia Sur), SERGAS-UVIGO, España.
| | - A Batalla
- Servicio de Dermatología, Complejo Hospitalario Universitario de Pontevedra, Pontevedra, España; Grupo de Investigación DIPO, Instituto de Investigación Sanitaria Galicia Sur (IIS Galicia Sur), SERGAS-UVIGO, España
| | - J M Carrascosa
- Servicio de Dermatología, Hospital Universitari Germans Trias i Pujol. Germans Trias I Pujol Research Institute (IGTP), Universitat Autònoma de Barcelona, Badalona, Barcelona, España
| | - P Chicharro
- Servicio de Dermatología, Hospital Universitario de la Princesa, Madrid, España
| | - A González-Quesada
- Servicio de Dermatología, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, España
| | - P de la Cueva
- Servicio de Dermatología, Hospital Universitario Infanta Leonor, Madrid, España
| | - A M Giménez-Arnau
- Servicio de Dermatología, Hospital del Mar, IMIM, Universitat Pompeu Fabra, Barcelona, España
| | - Y Gilaberte
- Servicio de Dermatología, Hospital Universitario Miguel Servet, Zaragoza, España
| | - M Rodríguez-Serna
- Servicio de Dermatología, Hospital Universitario y Politécnico la Fe, Valencia, España
| | - T Montero-Vilchez
- Servicio de Dermatología, Hospital Universitario Virgen de las Nieves, Granada. Instituto de Investigación IBS, Granada, España
| | - R Ruiz-Villaverde
- Servicio de Dermatología, Hospital Universitario San Cecilio, Granada, España
| | - M Elosua-González
- Servicio de Dermatología, Hospital Universitario Puerta del Hierro, Madrid, España
| | - J F Silvestre-Salvador
- Servicio de Dermatología, Hospital General Universitario Dr. Balmis, Alicante. ISABIAL, Alicante, España
| | - M Munera-Campos
- Servicio de Dermatología, Hospital Universitari Germans Trias i Pujol. Germans Trias I Pujol Research Institute (IGTP), Universitat Autònoma de Barcelona, Badalona, Barcelona, España
| | - J Sánchez-Pérez
- Servicio de Dermatología, Hospital Universitario de la Princesa, Madrid, España
| | - G Carretero
- Servicio de Dermatología, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, España
| | - C Mauleón-Fernández
- Servicio de Dermatología, Hospital Universitario Infanta Leonor, Madrid, España
| | - L Curto-Barredo
- Servicio de Dermatología, Hospital del Mar, IMIM, Universitat Pompeu Fabra, Barcelona, España
| | - A Ballano-Ruiz
- Servicio de Dermatología, Hospital Universitario Miguel Servet, Zaragoza, España
| | - R Botella-Estrada
- Servicio de Dermatología, Hospital Universitario y Politécnico la Fe, Valencia, España
| | - S Arias-Santiago
- Servicio de Dermatología, Hospital Universitario Virgen de las Nieves, Granada. Instituto de Investigación IBS, Granada, España
| | - F J Navarro-Triviño
- Servicio de Dermatología, Hospital Universitario San Cecilio, Granada, España
| | - G Roustan-Gullón
- Servicio de Dermatología, Hospital Universitario Puerta del Hierro, Madrid, España
| | - I Betlloch
- Servicio de Dermatología, Hospital General Universitario Dr. Balmis, Alicante. ISABIAL, Alicante, España
| | - E Del Alcázar
- Servicio de Dermatología, Hospital Universitari Germans Trias i Pujol. Germans Trias I Pujol Research Institute (IGTP), Universitat Autònoma de Barcelona, Badalona, Barcelona, España
| | - M T Abalde-Pintos
- Servicio de Dermatología, Complejo Hospitalario Universitario de Pontevedra, Pontevedra, España; Grupo de Investigación DIPO, Instituto de Investigación Sanitaria Galicia Sur (IIS Galicia Sur), SERGAS-UVIGO, España
| | - J Suárez-Perez
- Servicio de Dermatología, Hospital Clínico de Málaga, Málaga, España
| | - I García-Doval
- Unidad de Investigación, Fundación Piel Sana AEDV, España; Servicio de Dermatología, Complexo Hospitalario Universitario de Vigo, Vigo, España
| | - M Á Descalzo
- Unidad de Investigación, Fundación Piel Sana AEDV, España
| | - Á Flórez
- Servicio de Dermatología, Complejo Hospitalario Universitario de Pontevedra, Pontevedra, España; Grupo de Investigación DIPO, Instituto de Investigación Sanitaria Galicia Sur (IIS Galicia Sur), SERGAS-UVIGO, España
| |
Collapse
|
6
|
Tous-Romero F, Borrego-Hernando L, García-Doval I, Mercader-García P, Silvester-Salvador JF, Sánchez-Gilo A, Sanz-Sánchez T, Giménez-Arnau AM, Zaragoza-Ninet V, Miquel-Miquel J, González Pérez R, Córdoba-Guijarro S, Carrascosa-Carrillo JM, Gática-Ortega ME, Ruíz-González I, Serra-Baldrich E, Pastor-Nieto A, Rodríguez-Serna M, Sánchez-Pérez J, Melé I Ninot G, Sánchez-Pedreño Guillén P, Ortiz-de Frutos J. [Translated article] Four-year Epidemiological Surveillance of the Spanish Registry of Research in Contact Dermatitis and Cutaneous Allergy: Current Situation and Trends. Actas Dermosifiliogr 2024; 115:T331-T340. [PMID: 38331170 DOI: 10.1016/j.ad.2024.02.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2023] [Accepted: 10/31/2023] [Indexed: 02/10/2024] Open
Abstract
BACKGROUND The epidemiological surveillance of contact dermatitis is one of the objectives of the Spanish Registry of Research in Contact Dermatitis and Cutaneous Allergy. Knowing whether the prevalence of positive tests to the different allergens changes over time is important for this monitoring process. OBJECTIVES To describe the various temporary trends in allergen positivity in the GEIDAC standard series from 2018 through December 31, 2022. METHODS This was a multicenter, observational trial of consecutive patients analyzed via patch tests as part of the study of possible allergic contact dermatitises collected prospectively within the Spanish Registry of Research in Contact Dermatitis and Cutaneous Allergy. The data was analyzed using 2 statistical tests: one homogeneity test (to describe the changes seen over time) and one trend test (to see whether the changes described followed a linear trend). RESULTS A total of 11327 patients were included in the study. Overall, the allergens associated with a highest sensitization were nickel sulfate, methylisothiazolinone, cobalt chloride, methylchloroisothiazolinone/methylisothiazolinone, and fragrance mix i. A statistically significant decrease was found in the percentage of methylisothiazolinone positive tests across the study years with an orderly trend. CONCLUSIONS Although various changes were seen in the sensitizations trends to several allergens of the standard testing, it became obvious that a high sensitization to nickel, methylchloroisothiazolinone/methylisothiazolinone and fragrances mix i remained. Only a significant downward trend was seen for methylisothiazolinone.
Collapse
Affiliation(s)
- F Tous-Romero
- Servicio de Dermatología, Hospital Universitario 12 de Octubre, Madrid, Spain.
| | - L Borrego-Hernando
- Servicio de Dermatología, Hospital Universitario Insular de Gran Canaria, Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Las Palmas, Spain
| | - I García-Doval
- Unidad de Investigación, Fundación Piel Sana AEDV, Madrid, Spain
| | - P Mercader-García
- Servicio de Dermatología, Hospital General Universitario José M. Morales Meseguer, Murcia, Spain
| | | | - A Sánchez-Gilo
- Servicio de Dermatología, Hospital Rey Juan Carlos, Madrid, Spain
| | - T Sanz-Sánchez
- Servicio de Dermatología, Hospital Universitario Infanta Sofía, Madrid, Spain
| | | | - V Zaragoza-Ninet
- Servicio de Dermatología, Hospital Universitario de Valencia, Valencia, Spain
| | - J Miquel-Miquel
- Servicio de Dermatología, Hospital Universitario Arnau de Vilanova, Valencia, Spain
| | - R González Pérez
- Servicio de Dermatología, Hospital Universitario Araba, Vitoria, Álava, Spain
| | - S Córdoba-Guijarro
- Servicio de Dermatología, Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, Spain
| | - J M Carrascosa-Carrillo
- Servicio de Dermatología, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain
| | - M E Gática-Ortega
- Servicio de Dermatología, Complejo Hospitalario Universitario de Toledo, Toledo, Spain
| | - I Ruíz-González
- Servicio de Dermatología, Complejo Asistencial Universitario de León, León, Spain
| | - E Serra-Baldrich
- Servicio de Dermatología, Hospital de la Santa Creu i San Pau, Barcelona, Spain
| | - A Pastor-Nieto
- Servicio de Dermatología, Hospital Fundación Jiménez Díaz, Madrid, Spain
| | - M Rodríguez-Serna
- Servicio de Dermatología, Hospital Universitario La Fe, Valencia, Spain
| | - J Sánchez-Pérez
- Servicio de Dermatología, Hospital Universitario de La Princesa, Madrid, Spain
| | - G Melé I Ninot
- Servicio de Dermatología, Hospital Sagrat Cor, Barcelona, Spain
| | | | - J Ortiz-de Frutos
- Servicio de Dermatología, Hospital Universitario 12 de Octubre, Madrid, Spain
| |
Collapse
|
7
|
Tejera-Vaquerizo A, Boada A, Puig S, Nagore E, Fernández-de-Misa R, Ferrándiz L, Conde-Taboada A, Castro E, Richarz NA, Paradela S, Llambrich Á, Salgüero I, Diago A, Samaniego E, Flórez Á, Segura S, Maldonado-Seral C, Coronel-Pérez IM, Tomás-Velázquez A, Rodríguez P, Mayor A, García-Doval I, Grau-Pérez M. Melanoma Registry of the Spanish Academy of Dermatology and Venereology (REGESMEL): Description and Data in its First Year of Operation. Actas Dermosifiliogr 2024:S0001-7310(24)00184-4. [PMID: 38452890 DOI: 10.1016/j.ad.2024.02.027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2023] [Revised: 01/24/2024] [Accepted: 02/25/2024] [Indexed: 03/09/2024] Open
Abstract
INTRODUCTION The incidence of melanoma is rising in Spain. The prognostic stages of patients with melanoma are determined by various biological factors, such as tumor thickness, ulceration, or the presence of regional or distant metastases. The Spanish Academy of Dermatology and Venereology (AEDV) has encouraged the creation of a Spanish Melanoma Registry (REGESMEL) to evaluate other individual and health system-related factors that may impact the prognosis of patients with melanoma. The aim of this article is to introduce REGESMEL and provide basic descriptive data for its first year of operation. METHODS REGESMEL is a prospective, multicentre cohort of consecutive patients with invasive cutaneous melanoma that collects demographic and staging data as well as individual and healthcare-related baseline data. It also records the medical and surgical treatment received by patients. RESULTS A total of 450 cases of invasive cutaneous melanoma from 19 participant centres were included, with a predominance of thin melanomas≤1mm thick (54.7%), mainly located on the posterior trunk (35.2%). Selective sentinel lymph node biopsy was performed in 40.7% of cases. Most cases of melanoma were suspected by the patient (30.4%), or his/her dermatologist (29.6%). Patients received care mainly in public health centers (85.2%), with tele-dermatology resources being used in 21.6% of the cases. CONCLUSIONS The distribution of the pathological and demographic variables of melanoma cases is consistent with data from former studies. REGESMEL has already recruited patients from 15 Spanish provinces and given its potential representativeness, it renders the Registry as an important tool to address a wide range of research questions.
Collapse
Affiliation(s)
| | - A Boada
- Servicio de Dermatología, Hospital Universitari Germans Trias i Pujol, Institut d'Investigació Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, España
| | - S Puig
- Servicio de Dermatología, Hospital Clínic de Barcelona, IDIBAPS, Universidad de Barcelona, Barcelona, España; Centro de investigación biomédica en red de enfermedades raras, CIBERER, Barcelona, España
| | - E Nagore
- Servicio de Dermatología, Instituto Valenciano de Oncología, Valencia, España
| | - R Fernández-de-Misa
- Servicio de Dermatología, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, España
| | - L Ferrándiz
- Unidad de Melanoma, Servicio de Dermatología médico-quirúrgico, Hospital Universitario Virgen Macarena, Sevilla, España
| | - A Conde-Taboada
- Servicio de Dermatología, Hospital Clínico San Carlos, Madrid, España
| | - E Castro
- Servicio de Dermatología, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, España
| | - N A Richarz
- Servicio de Dermatología, Hospital Universitari Germans Trias i Pujol, Institut d'Investigació Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, España
| | - S Paradela
- Servicio de Dermatología, Complexo Hospitalario A Coruña, A Coruña, España
| | - Á Llambrich
- Servicio de Dermatología, Hospital Universitario Son Llàtzer, Palma de Mallorca, España
| | - I Salgüero
- Servicio de Dermatología, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, España
| | - A Diago
- Servicio de Dermatología, Hospital Universitario Miguel Servet, Zaragoza, España
| | - E Samaniego
- Servicio de Dermatología, Complejo Asistencial Universitario de León, León, España
| | - Á Flórez
- Servicio de Dermatología, Complejo Hospitalario Universitario de Pontevedra, Grupo de Investigación DIPO, Instituto de Investigación Sanitaria Galicia Sur, SERGAS-UVIGO, Pontevedra, España
| | - S Segura
- Servicio de Dermatología, Hospital del Mar de Barcelona, Barcelona, España
| | - C Maldonado-Seral
- Servicio de Dermatología, Hospital Universitario Central de Asturias, Oviedo, España
| | - I M Coronel-Pérez
- Servicio de Dermatología, Hospital Universitario Virgen de Valme de Sevilla, Sevilla, España
| | - A Tomás-Velázquez
- Servicio de Dermatología, Clínica Universidad de Navarra, Madrid, España
| | - P Rodríguez
- Servicio de Dermatología, Hospital Universitario La Princesa, Madrid, España; Servicio de Dermatología, Hospital Ruber Internacional, Madrid, España
| | - A Mayor
- Servicio de Dermatología, Hospital Universitario La Paz, Madrid, España
| | - I García-Doval
- Unidad de Investigación, Academia Española de Dermatología y Venereología, Madrid, España; Servicio de Dermatología, Complexo Hospitalario Universitario de Vigo, Vigo, España
| | - M Grau-Pérez
- Unidad de Investigación, Academia Española de Dermatología y Venereología, Madrid, España; Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, España.
| |
Collapse
|
8
|
Sánchez-Díaz M, Flórez Á, Ara-Martín M, Arias-Santiago S, Botella-Estrada R, Cañueto J, Carretero-Hernández G, Coto-Segura P, de Eusebio-Murillo E, García-Latasa de Araníbar FJ, García-Patos Briones V, Gardeazabal García J, Gómez-Fernández C, Hernández-Ostiz S, Izu Belloso R, López-Ávila A, Manchado López P, Martín-Santiago A, Martinez de Espronceda Ezquerro I, Mateu-Puchades A, Mercader-García P, Notario Rosa J, Palacio Aller L, Pérez-Hortet C, Quintana-Castanedo L, Rivera R, Rocamora Duran V, Rodríguez-Nevado IM, Ruiz-Villaverde R, Suárez J, Trasobares-Marugán L, Vizán-de Uña C, Yanguas I, Zulaica-Garate A, García-Doval I, Descalzo MÁ, Grau-Pérez M, Carrascosa-Carrillo JM. [Translated article] Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study. Actas Dermosifiliogr 2024; 115:T237-T245. [PMID: 38242435 DOI: 10.1016/j.ad.2024.01.019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2023] [Accepted: 10/09/2023] [Indexed: 01/21/2024] Open
Abstract
BACKGROUND Although the Spanish Ministry of Health prepares national therapeutic positioning reports (TPRs) and drug reimbursement policies, each of the country's 17 autonomous communities (ACs) is responsible for health care services and prescription requirements in its territory. The aim of the EQUIDAD study was to describe and explore potential differences in prescription requirements for new dermatology drugs across the autonomous communities. MATERIAL AND METHODS Cross-sectional study conducted in April and May, 2023. Two dermatologists with management responsibilities from each autonomous community reported on territorial and more local prescription requirements for drugs covered by national TPRs issued between 2016 and 2022. RESULTS Thirty-three researchers from 17 autonomous communities participated. The data submitted revealed between-community inequities in access to new drugs. Overall, 64.7% of the regions imposed additional prescription requirements to those mentioned in the TPRs for psoriasis. This percentage was lower for atopic dermatitis (35.3%) and melanoma (11.8%). The most common requirement for accessing a new drug was a previous prescription for another drug. Differences and additional requirements were also detected at the local level (i.e., differences between hospitals within the same autonomous community). CONCLUSIONS Spain's autonomous communities have multiple regional and local prescription requirements that are not aligned with national TPR recommendations. These differences result in inequitable access to new drugs for both patients and practitioners across Spain.
Collapse
Affiliation(s)
- M Sánchez-Díaz
- Unidad de Investigación, Academia Española de Dermatología y Venereología, Madrid, Spain; Servicio de Dermatología, Hospital Universitario Virgen de las Nieves, Instituto de Investigación Biosanitaria IBS, Granada, Spain
| | - Á Flórez
- Servicio de Dermatología, Complejo Hospitalario Universitario de Pontevedra, Grupo de Investigación DIPO, IIS Galicia Sur-SERGAS-UVIGO, Pontevedra, Spain
| | - M Ara-Martín
- Servicio de Dermatología, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain
| | - S Arias-Santiago
- Servicio de Dermatología, Hospital Universitario Virgen de las Nieves, Instituto de Investigación Biosanitaria IBS, Granada, Spain
| | - R Botella-Estrada
- Servicio de Dermatología, Hospital Universitario La Fe, Valencia, Spain
| | - J Cañueto
- Servicio de Dermatología, Complejo Asistencial Universitario de Salamanca, Salamanca, Spain
| | - G Carretero-Hernández
- Servicio de Dermatología, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain
| | - P Coto-Segura
- Servicio de Dermatología, Hospital Vital Alvarez-Buylla, Mieres, Asturias, Spain
| | - E de Eusebio-Murillo
- Servicio de Dermatología, Hospital Universitario de Guadalajara, Guadalajara, Spain
| | | | - V García-Patos Briones
- Servicio de Dermatología, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain
| | - J Gardeazabal García
- Servicio de Dermatología, Hospital Universitario Cruces, Barakaldo, Vizcaya, Spain
| | - C Gómez-Fernández
- Servicio de Dermatología, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain
| | - S Hernández-Ostiz
- Servicio de Dermatología, Hospital de Calahorra, Calahorra, La Rioja, Spain
| | - R Izu Belloso
- Servicio de Dermatología, Hospital Universitario Basurto, Bilbao, Vizcaya, Spain
| | - A López-Ávila
- Servicio de Dermatología, Hospital General Universitario Santa María del Rosell, Cartagena, Spain
| | - P Manchado López
- Servicio de Dermatología, Hospital Clínico Universitario de Valladolid, Valladolid, Spain
| | - A Martín-Santiago
- Servicio de Dermatología, Hospital Universitari Son Espases, Palma de Mallorca, Baleares, Spain
| | | | - A Mateu-Puchades
- Servicio de Dermatología, Hospital Universitario Doctor Peset, Valencia, Spain
| | | | - J Notario Rosa
- Servicio de Dermatología, Hospital Universitario de Bellvitge, L' Hospitalet de Llobregat, Barcelona, Spain
| | - L Palacio Aller
- Servicio de Dermatología, Hospital de Cabueñes, Gijón, Asturias, Spain
| | - C Pérez-Hortet
- Servicio de Dermatología, Hospital Universitario de Toledo, Toledo, Spain
| | - L Quintana-Castanedo
- Servicio de Dermatología, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain
| | - R Rivera
- Servicio de Dermatología, Hospital Universitario 12 de Octubre, Madrid, Spain
| | - V Rocamora Duran
- Servicio de Dermatología, Hospital de Manacor, Manacor, Baleares, Spain
| | - I M Rodríguez-Nevado
- Servicio de Dermatología, Complejo Hospitalario Universitario de Badajoz, Badajoz, Spain
| | - R Ruiz-Villaverde
- Servicio de Dermatología, Hospital Universitario San Cecilio, Granada, Spain
| | - J Suárez
- Servicio de Dermatología, Hospital Universitario Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, Spain
| | - L Trasobares-Marugán
- Servicio de Dermatología, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain
| | - C Vizán-de Uña
- Servicio de Dermatología, Hospital Universitario de Cáceres, Cáceres, Spain
| | - I Yanguas
- Servicio de Dermatología, Hospital Universitario de Navarra, Pamplona, Spain
| | - A Zulaica-Garate
- Servicio de Dermatología, Hospital do Meixoeiro, Vigo, Pontevedra, Spain
| | - I García-Doval
- Unidad de Investigación, Fundación Piel Sana AEDV, Madrid, Spain
| | - M Á Descalzo
- Unidad de Investigación, Fundación Piel Sana AEDV, Madrid, Spain
| | - M Grau-Pérez
- Unidad de Investigación, Fundación Piel Sana AEDV, Madrid, Spain; Servicio de Dermatología, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.
| | - J M Carrascosa-Carrillo
- Servicio de Dermatología, Hospital Universitario Germans Trias i Pujol, Badalona, Barcelona, Spain
| |
Collapse
|
9
|
Sánchez-Díaz M, Flórez Á, Ara-Martín M, Arias-Santiago S, Botella-Estrada R, Cañueto J, Carretero-Hernández G, Coto-Segura P, de Eusebio-Murillo E, García-Latasa de Araníbar FJ, García-Patos Briones V, Gardeazabal García J, Gómez-Fernández C, Hernández-Ostiz S, Izu Belloso R, López-Ávila A, Manchado López P, Martín-Santiago A, Martinez de Espronceda Ezquerro I, Mateu-Puchades A, Mercader-García P, Notario Rosa J, Palacio Aller L, Pérez-Hortet C, Quintana-Castanedo L, Rivera R, Rocamora Duran V, Rodríguez-Nevado IM, Ruiz-Villaverde R, Suárez J, Trasobares-Marugán L, Vizán-de Uña C, Yanguas I, Zulaica-Garate A, García-Doval I, Descalzo MÁ, Grau-Pérez M, Carrascosa-Carrillo JM. Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study. Actas Dermosifiliogr 2024; 115:237-245. [PMID: 37890617 DOI: 10.1016/j.ad.2023.10.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2023] [Revised: 09/26/2023] [Accepted: 10/09/2023] [Indexed: 10/29/2023] Open
Abstract
BACKGROUND Although the Spanish Ministry of Health prepares national therapeutic positioning reports (TPRs) and drug reimbursement policies, each of the country's 17 autonomous communities (ACs) is responsible for health care services and prescription requirements in its territory. The aim of the EQUIDAD study was to describe and explore potential differences in prescription requirements for new dermatology drugs across the autonomous communities. MATERIAL AND METHODS Cross-sectional study conducted in April and May, 2023. Two dermatologists with management responsibilities from each autonomous community reported on territorial and more local prescription requirements for drugs covered by national TPRs issued between 2016 and 2022. RESULTS Thirty-three researchers from 17 autonomous communities participated. The data submitted revealed between-community inequities in access to new drugs. Overall, 64.7% of the regions imposed additional prescription requirements to those mentioned in the TPRs for psoriasis. This percentage was lower for atopic dermatitis (35.3%) and melanoma (11.8%). The most common requirement for accessing a new drug was a previous prescription for another drug. Differences and additional requirements were also detected at the local level (i.e., differences between hospitals within the same autonomous community). CONCLUSIONS Spain's autonomous communities have multiple regional and local prescription requirements that are not aligned with national TPR recommendations. These differences result in inequitable access to new drugs for both patients and practitioners across Spain.
Collapse
Affiliation(s)
- M Sánchez-Díaz
- Unidad de Investigación, Academia Española de Dermatología y Venereología, Madrid, España; Servicio de Dermatología, Hospital Universitario Virgen de las Nieves, Instituto de Investigación Biosanitaria IBS, Granada, España
| | - Á Flórez
- Servicio de Dermatología, Complejo Hospitalario Universitario de Pontevedra, Grupo de Investigación DIPO, IIS Galicia Sur-SERGAS-UVIGO, Pontevedra, España
| | - M Ara-Martín
- Servicio de Dermatología, Hospital Clínico Universitario Lozano Blesa, Zaragoza, España
| | - S Arias-Santiago
- Servicio de Dermatología, Hospital Universitario Virgen de las Nieves, Instituto de Investigación Biosanitaria IBS, Granada, España
| | - R Botella-Estrada
- Servicio de Dermatología, Hospital Universitario La Fe, Valencia, España
| | - J Cañueto
- Servicio de Dermatología, Complejo Asistencial Universitario de Salamanca, Salamanca, España
| | - G Carretero-Hernández
- Servicio de Dermatología, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, España
| | - P Coto-Segura
- Servicio de Dermatología, Hospital Vital Alvarez-Buylla, Mieres, Asturias, España
| | - E de Eusebio-Murillo
- Servicio de Dermatología, Hospital Universitario de Guadalajara, Guadalajara, España
| | | | - V García-Patos Briones
- Servicio de Dermatología, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, España
| | - J Gardeazabal García
- Servicio de Dermatología, Hospital Universitario Cruces, Barakaldo, Vizcaya, España
| | - C Gómez-Fernández
- Servicio de Dermatología, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, España
| | - S Hernández-Ostiz
- Servicio de Dermatología, Hospital de Calahorra, Calahorra, La Rioja, España
| | - R Izu Belloso
- Servicio de Dermatología, Hospital Universitario Basurto, Bilbao, Vizcaya, España
| | - A López-Ávila
- Servicio de Dermatología, Hospital General Universitario Santa María del Rosell, Cartagena, España
| | - P Manchado López
- Servicio de Dermatología, Hospital Clínico Universitario de Valladolid, Valladolid, España
| | - A Martín-Santiago
- Servicio de Dermatología, Hospital Universitari Son Espases, Palma de Mallorca, Baleares, España
| | | | - A Mateu-Puchades
- Servicio de Dermatología, Hospital Universitario Doctor Peset, Valencia, España
| | | | - J Notario Rosa
- Servicio de Dermatología, Hospital Universitario de Bellvitge, L' Hospitalet de Llobregat, Barcelona, España
| | - L Palacio Aller
- Servicio de Dermatología, Hospital de Cabueñes, Gijón, Asturias, España
| | - C Pérez-Hortet
- Servicio de Dermatología, Hospital Universitario de Toledo, Toledo, España
| | - L Quintana-Castanedo
- Servicio de Dermatología, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, España
| | - R Rivera
- Servicio de Dermatología, Hospital Universitario 12 de Octubre, Madrid, España
| | - V Rocamora Duran
- Servicio de Dermatología, Hospital de Manacor, Manacor, Baleares, España
| | - I M Rodríguez-Nevado
- Servicio de Dermatología, Complejo Hospitalario Universitario de Badajoz, Badajoz, España
| | - R Ruiz-Villaverde
- Servicio de Dermatología, Hospital Universitario San Cecilio, Granada, España
| | - J Suárez
- Servicio de Dermatología, Hospital Universitario Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, España
| | - L Trasobares-Marugán
- Servicio de Dermatología, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, España
| | - C Vizán-de Uña
- Servicio de Dermatología, Hospital Universitario de Cáceres, Cáceres, España
| | - I Yanguas
- Servicio de Dermatología, Hospital Universitario de Navarra, Pamplona, España
| | - A Zulaica-Garate
- Servicio de Dermatología, Hospital do Meixoeiro, Vigo, Pontevedra, España
| | - I García-Doval
- Unidad de Investigación, Fundación Piel Sana AEDV, Madrid, España
| | - M Á Descalzo
- Unidad de Investigación, Fundación Piel Sana AEDV, Madrid, España
| | - M Grau-Pérez
- Unidad de Investigación, Fundación Piel Sana AEDV, Madrid, España; Servicio de Dermatología, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, España.
| | - J M Carrascosa-Carrillo
- Servicio de Dermatología, Hospital Universitario Germans Trias i Pujol, Badalona, Barcelona, España
| |
Collapse
|
10
|
Verdaguer-Faja J, Borrego L, Mercader-García P, González Pérez R, Córdoba-Guijarro S, Giménez-Arnau AM, Ruiz-González I, Miquel-Miquel J, Silvestre JF, Ortiz de Frutos FJ, Tous-Romero F, Sanz Sánchez T, Rodríguez-Serna M, Sánchez-Pérez J, Serra Baldrich E, Zaragoza-Ninet V, Pastor-Nieto MA, Gática-Ortega ME, Sánchez Gilo A, Melé-Ninot G, Sánchez-Pedreño Guillén P, Munera-Campos M, Descalzo MÁ, García-Doval I, Carrascosa JM. Epidemiological, Clinical, and Allergic Profile of Psoriatic Patients. Evaluation of the Spanish Registry of Contact Dermatitis and Cutaneous Allergy (REIDAC). Actas Dermosifiliogr 2024:S0001-7310(24)00150-9. [PMID: 38382750 DOI: 10.1016/j.ad.2024.02.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2023] [Revised: 12/18/2023] [Accepted: 02/06/2024] [Indexed: 02/23/2024] Open
Abstract
BACKGROUND Psoriasis is a chronic inflammatory dermatosis whose clinical and topographic distribution requires differential diagnosis, or the possible association with allergic contact dermatitis (ACD), requiring patch testing (PT) as part of the diagnostic procedure. OBJECTIVES To describe the epidemiological, clinical, and allergic profile of patients with a primary or secondary diagnosis of psoriasis undergoing PT and compare them with patients with a diagnosis of ACD at the end of the diagnostic process. METHODS Cross-sectional study with data from REIDAC from 2018 through 2023 of selected patients with a diagnosis of psoriasis and/or ACD. RESULTS A total of 11 502 patients were included, 513 of whom had been diagnosed with primary or secondary psoriasis, 3640 with ACD, and 108 with both diseases. Men were more predominant in the groups of patients with psoriasis, psoriasis+ACD, and lesions were more predominantly seen in the hands with little association with atopic factors vs the ACD group. The rate of positivity in PT to the 2022 Spanish battery of allergens was lower in the group with psoriasis only in 27% of the patients. The most common allergens found in the psoriasis group were also the most common ones found in the overall ACD population. CONCLUSIONS Overall, 36.2% of psoriatic patients tested positive in PT to the 2022 Spanish battery of allergens, which proved that this association is not uncommon. Overall, psoriatic patients had a higher mean age, were more predominantly men, and showed more hand involvement.
Collapse
Affiliation(s)
- J Verdaguer-Faja
- Servicio de Dermatología, Hospital Universitari Germans Trias i Pujol, Badalona, España.
| | - L Borrego
- Servicio de Dermatología, Complejo Hospitalario Universitario Insular, Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Las Palmas, España
| | - P Mercader-García
- Servicio de Dermatología, Hospital General Universitario Morales Meseguer, Murcia, España
| | - R González Pérez
- Servicio de Dermatología, Hospital Universitario De Araba, Universidad del País Vasco, Vitoria-Gasteiz, España
| | - S Córdoba-Guijarro
- Servicio de Dermatología, Hospital Universitario de Fuenlabrada, Fuenlabrada, España
| | - A M Giménez-Arnau
- Servicio de Dermatología, Hospital del Mar, Research Institute, Universitat Pompeu Fabra, Barcelona, España
| | - I Ruiz-González
- Servicio de Dermatología, Complejo Asistencial Universitario de León, León, España
| | - J Miquel-Miquel
- Servicio de Dermatología, Hospital Arnau de Vilanova, Valencia, España
| | - J F Silvestre
- Servicio de Dermatología, Hospital General Universitario Dr. Balmis, ISABIAL, Alicante, España
| | - F J Ortiz de Frutos
- Servicio de Dermatología, Hospital Universitario 12 de Octubre, Madrid, España
| | - F Tous-Romero
- Servicio de Dermatología, Hospital Universitario 12 de Octubre, Madrid, España
| | - T Sanz Sánchez
- Servicio de Dermatología, Hospital Universitario Infanta Sofía, Madrid, España
| | - M Rodríguez-Serna
- Servicio de Dermatología, Hospital Universitario La Fe, Valencia, España
| | - J Sánchez-Pérez
- Servicio de Dermatología, Hospital Universitario La Princesa, Madrid, España
| | - E Serra Baldrich
- Servicio de Dermatología, Hospital de La Santa Creu i San Pau, Barcelona, España
| | - V Zaragoza-Ninet
- Servicio de Dermatología, Consorcio Hospital General Universitario de Valencia, Valencia, España
| | - M A Pastor-Nieto
- Servicio de Dermatología, Hospital Universitario de Guadalajara, Guadalajara, España
| | - M E Gática-Ortega
- Servicio de Dermatología, Hospital Virgen del Valle Complejo Hospitalario de Toledo, Toledo, España
| | - A Sánchez Gilo
- Servicio de Dermatología, Hospital Universitario Rey Juan Carlos Móstoles, Móstoles, España
| | - G Melé-Ninot
- Servicio de Dermatología, Hospital Universitari Sagrat Cor, Grupo Quirónsalud, Barcelona, España
| | | | - M Munera-Campos
- Servicio de Dermatología, Hospital Universitari Germans Trias i Pujol, Badalona, España
| | - M Á Descalzo
- Unidad de Investigación, Fundación Piel Sana, Madrid, España
| | - I García-Doval
- Unidad de Investigación, Fundación Piel Sana, Madrid, España
| | - J M Carrascosa
- Servicio de Dermatología, Hospital Universitari Germans Trias i Pujol, Badalona, España; Departamento de Medicina, Universitat Autònoma de Barcelona (UAB), IGTP, Barcelona, España
| |
Collapse
|
11
|
Galván Casas C, Ruiz-Villaverde R, Prados-Carmona Á, Fernández Camporro Á, Angulo Menéndez AG, Álvarez-Buylla Puente MC, Pasquali P, Aguado Vázquez Á, Masferrer E, Rodríguez González L, Ruiz-Sánchez D, Caballero-Linares CF, Tejera-Vaquerizo A, Iglesias-Pena N, Fernández de Piérola S, Maldonado-Seral C, Armengot-Carbó M, Alonso-Naranjo L, Barros Tornay R, Solano Novo T, Fernández Tapia V, Martín-Gorgojo A, Adsuar Mas J, Parera Amer ME, Pérez Feal P, Taberner R, Utrera-Busquets M, Vicente Sánchez I, Palacio Aller L, Sánchez-Gutiérrez I, Usero-Bárcena T, Aldea Manrique B, Sánchez Velázquez A, Martínez García E, Grau-Pérez M, García-Doval I. Clinical and Epidemiological Characteristics of Patients Being Treated for Scabies in Spain: Opportunities for Improvement - A Multicenter Cross-Sectional CLINI-AEDV Study. Actas Dermosifiliogr 2024; 115:36-47. [PMID: 37678633 DOI: 10.1016/j.ad.2023.08.006] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2023] [Revised: 08/22/2023] [Accepted: 08/28/2023] [Indexed: 09/09/2023] Open
Abstract
BACKGROUND Several studies support the hypothesis that scabies is on the rise in Spain. There are also concerns about the possible development of resistance to treatment and an increase in atypical presentations. The aims of this study were to describe the demographic and clinical characteristics of patients with scabies seen by dermatologists in Spain, to identify the possible emergence of atypical forms of scabies, and to explore the frequency of treatment failures and associated risk factors. METHODS We conducted an observational, cross-sectional, multicenter study of data collected prospectively in April and May 2023 using the CLINI-AEDVp platform created by the Spanish Academy of Dermatology and Venereology (AEDV). RESULTS Participating dermatologists from 31 hospitals in 15 of Spain's autonomous communities recorded 186 cases of active scabies (51% in women) during the study period. A diagnostic certainty level of A, B or C as per the International Alliance for the Control of Scabies Consensus Criteria was required for diagnosis. Overall, 92% of patients had typical scabies and 66% had already been treated with a scabicide for the current episode. Of the treated patients, only 36% had received and completed adequate treatment (including the simultaneous treatment of all household members) and 50% had not received clear written recommendations. CONCLUSIONS In a high proportion of the cases of scabies studied, the patient had already received treatment. In those cases, we observed several remediable shortcomings that could explain why some of these treatments had failed. Remedying these deficiencies should lead to better control of scabies and an improved assessment of the actual effectiveness of currently available scabicides.
Collapse
Affiliation(s)
- C Galván Casas
- Unidad de Investigación STI & NTD, Fundación Lucha contra las Infecciones, Badalona, Barcelona, España; Servicio de Dermatología, Hospital Universitario de Móstoles, Móstoles, Madrid, España
| | - R Ruiz-Villaverde
- Servicio de Dermatología, Hospital Universitario San Cecilio, Granada, España
| | - Á Prados-Carmona
- Servicio de Dermatología, Hospital Universitario San Cecilio, Granada, España
| | - Á Fernández Camporro
- Servicio de Dermatología, Hospital Universitario de Cabueñes, Gijón, Asturias, España
| | | | | | - P Pasquali
- Centro Médico Pasquali & Asociados, Cambrils, Tarragona, España
| | - Á Aguado Vázquez
- Servicio de Dermatología, Hospital Universitario Doctor Peset, Valencia, España
| | | | | | - D Ruiz-Sánchez
- Servicio de Dermatología, Hospital Universitario de Cabueñes, Gijón, Asturias, España
| | - C F Caballero-Linares
- Servicio de Dermatología, Hospital Universitario Puerta de Hierro-Majadahonda, Majadahonda, Madrid, España
| | | | - N Iglesias-Pena
- Servicio de Dermatología, Hospital San Rafael, A Coruña, España
| | | | - C Maldonado-Seral
- Servicio de Dermatología, Hospital Universitario Central de Asturias, Oviedo, Asturias, España
| | - M Armengot-Carbó
- Servicio de Dermatología, Hospital General Universitario de Castellón, Castellón, España
| | | | - R Barros Tornay
- Servicio de Dermatología, Hospital Universitario de Cabueñes, Gijón, Asturias, España
| | | | - V Fernández Tapia
- Servicio de Dermatología, Hospital Universitario Son Llàtzer, Palma, Palma de Mallorca, España
| | - A Martín-Gorgojo
- Servicio ITS/Dermatología, Sección Especialidades Médicas, Ayuntamiento de Madrid, Madrid, España
| | - J Adsuar Mas
- Servicio de Dermatología, Hospital Universitario Son Llàtzer, Palma, Palma de Mallorca, España
| | - M E Parera Amer
- Servicio de Dermatología, Hospital Universitario Son Llàtzer, Palma, Palma de Mallorca, España
| | - P Pérez Feal
- Servicio de Dermatología, Hospital Universitario Lucus Augusti, Lugo, España
| | - R Taberner
- Servicio de Dermatología, Hospital Universitario Son Llàtzer, Palma, Palma de Mallorca, España
| | | | - I Vicente Sánchez
- Organización sanitaria Integrada Barrualde-Galdakao, Vizcaya, España
| | - L Palacio Aller
- Servicio de Dermatología, Hospital Universitario de Cabueñes, Gijón, Asturias, España
| | - I Sánchez-Gutiérrez
- Servicio de Dermatología, Hospital Universitario Puerta de Hierro-Majadahonda, Majadahonda, Madrid, España
| | - T Usero-Bárcena
- Servicio de Dermatología, Hospital Universitario Lucus Augusti, Lugo, España
| | - B Aldea Manrique
- Servicio de Dermatología, Hospital Universitario Miguel Servet, Zaragoza, España
| | - A Sánchez Velázquez
- Servicio de Dermatología, Hospital Universitario 12 de Octubre, Madrid, España
| | - E Martínez García
- Servicio de Dermatología, Hospital Universitario Virgen de la Victoria, Málaga, España
| | - M Grau-Pérez
- Servicio de Dermatología, Hospital Universitario Puerta de Hierro-Majadahonda, Majadahonda, Madrid, España; Unidad de Investigación, Academia Española de Dermatología y Venereología (AEDV), Madrid, España.
| | - I García-Doval
- Unidad de Investigación, Academia Española de Dermatología y Venereología (AEDV), Madrid, España
| |
Collapse
|
12
|
Galván Casas C, Ruiz-Villaverde R, Prados-Carmona Á, Fernández Camporro Á, Angulo Menéndez AG, Álvarez-Buylla Puente MC, Pasquali P, Aguado Vázquez Á, Masferrer E, Rodríguez González L, Ruiz-Sánchez D, Caballero-Linares CF, Tejera-Vaquerizo A, Iglesias-Pena N, Fernández de Piérola S, Maldonado-Seral C, Armengot-Carbó M, Alonso-Naranjo L, Barros Tornay R, Solano Novo T, Fernández Tapia V, Martín-Gorgojo A, Adsuar Mas J, Parera Amer ME, Pérez Feal P, Taberner R, Utrera-Busquets M, Vicente Sánchez I, Palacio Aller L, Sánchez-Gutiérrez I, Usero-Bárcena T, Aldea Manrique B, Sánchez Velázquez A, Martínez García E, Grau-Pérez M, García-Doval I. [Translated article] Clinical and Epidemiological Characteristics of Patients Being Treated for Scabies in Spain: Opportunities for Improvement - A Multicenter Cross-Sectional CLINI-AEDV Study. Actas Dermo-Sifiliográficas 2024; 115:T36-T47. [PMID: 37923079 DOI: 10.1016/j.ad.2023.10.037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2023] [Accepted: 08/28/2023] [Indexed: 11/07/2023] Open
Abstract
BACKGROUND Several studies support the hypothesis that scabies is on the rise in Spain. There are also concerns about the possible development of resistance to treatment and an increase in atypical presentations. The aims of this study were to describe the demographic and clinical characteristics of patients with scabies seen by dermatologists in Spain, to identify the possible emergence of atypical forms of scabies, and to explore the frequency of treatment failures and associated risk factors. METHODS We conducted an observational, cross-sectional, multicenter study of data collected prospectively in April and May 2023 using the CLINI-AEDVp platform created by the Spanish Academy of Dermatology and Venereology (AEDV). RESULTS Participating dermatologists from 31 hospitals in 15 of Spain's autonomous communities recorded 186 cases of active scabies (51% in women) during the study period. A diagnostic certainty level of A, B or C as per the International Alliance for the Control of Scabies Consensus Criteria was required for diagnosis. Overall, 92% of patients had clinical features of classic scabies and 66% had already been treated with a scabicide for the current episode. Of the treated patients, only 36% had received and completed adequate treatment (including the simultaneous treatment of all household members) and 50% had not received clear written recommendations. CONCLUSIONS In a high proportion of scabies cases, the patient has already received treatment. In those cases, we observe several remediable shortcomings that could explain why some of these treatments fail. Remedying these deficiencies should lead to better control of scabies and an improved assessment of the actual effectiveness of currently available scabicides.
Collapse
Affiliation(s)
- C Galván Casas
- Unidad de Investigación STI & NTD, Fundación Lucha contra las Infecciones, Badalona, Barcelona, España; Servicio de Dermatología, Hospital Universitario de Móstoles, Móstoles, Madrid, España
| | - R Ruiz-Villaverde
- Servicio de Dermatología, Hospital Universitario San Cecilio, Granada, España
| | - Á Prados-Carmona
- Servicio de Dermatología, Hospital Universitario San Cecilio, Granada, España
| | - Á Fernández Camporro
- Servicio de Dermatología, Hospital Universitario de Cabueñes, Gijón, Asturias, España
| | | | | | - P Pasquali
- Centro Médico Pasquali & Asociados, Cambrils, Tarragona, España
| | - Á Aguado Vázquez
- Servicio de Dermatología, Hospital Universitario Doctor Peset, Valencia, España
| | | | | | - D Ruiz-Sánchez
- Servicio de Dermatología, Hospital Universitario de Cabueñes, Gijón, Asturias, España
| | - C F Caballero-Linares
- Servicio de Dermatología, Hospital Universitario Puerta de Hierro-Majadahonda, Majadahonda, Madrid, España
| | | | - N Iglesias-Pena
- Servicio de Dermatología, Hospital San Rafael, A Coruña, España
| | | | - C Maldonado-Seral
- Servicio de Dermatología, Hospital Universitario Central de Asturias, Oviedo, Asturias, España
| | - M Armengot-Carbó
- Servicio de Dermatología, Hospital General Universitario de Castellón, Castellón, España
| | | | - R Barros Tornay
- Servicio de Dermatología, Hospital Universitario de Cabueñes, Gijón, Asturias, España
| | | | - V Fernández Tapia
- Servicio de Dermatología, Hospital Universitario Son Llàtzer, Palma, Palma de Mallorca, España
| | - A Martín-Gorgojo
- Servicio ITS/Dermatología, Sección Especialidades Médicas, Ayuntamiento de Madrid, Madrid, España
| | - J Adsuar Mas
- Servicio de Dermatología, Hospital Universitario Son Llàtzer, Palma, Palma de Mallorca, España
| | - M E Parera Amer
- Servicio de Dermatología, Hospital Universitario Son Llàtzer, Palma, Palma de Mallorca, España
| | - P Pérez Feal
- Servicio de Dermatología, Hospital Universitario Lucus Augusti, Lugo, España
| | - R Taberner
- Servicio de Dermatología, Hospital Universitario Son Llàtzer, Palma, Palma de Mallorca, España
| | | | - I Vicente Sánchez
- Organización sanitaria Integrada Barrualde-Galdakao, Vizcaya, España
| | - L Palacio Aller
- Servicio de Dermatología, Hospital Universitario de Cabueñes, Gijón, Asturias, España
| | - I Sánchez-Gutiérrez
- Servicio de Dermatología, Hospital Universitario Puerta de Hierro-Majadahonda, Majadahonda, Madrid, España
| | - T Usero-Bárcena
- Servicio de Dermatología, Hospital Universitario Lucus Augusti, Lugo, España
| | - B Aldea Manrique
- Servicio de Dermatología, Hospital Universitario Miguel Servet, Zaragoza, España
| | - A Sánchez Velázquez
- Servicio de Dermatología, Hospital Universitario 12 de Octubre, Madrid, España
| | - E Martínez García
- Servicio de Dermatología, Hospital Universitario Virgen de la Victoria, Málaga, España
| | - M Grau-Pérez
- Servicio de Dermatología, Hospital Universitario Puerta de Hierro-Majadahonda, Majadahonda, Madrid, España; Unidad de Investigación, Academia Española de Dermatología y Venereología (AEDV), Madrid, España.
| | - I García-Doval
- Unidad de Investigación, Academia Española de Dermatología y Venereología (AEDV), Madrid, España
| |
Collapse
|
13
|
Martin-Gorgojo A, Del Boz J, Descalzo-Gallego MÁ, Arias-Santiago S, Molina-Leyva A, Gilaberte Y, Fernández-Crehuet P, Husein-ElAhmed H, Viera-Ramírez A, Fernández-Peñas P, Taberner R, Buendía-Eisman A, García-Doval I. What Proportion of the Spanish Dermatology Caseload Corresponds to Pediatric Dermatoses? Results From the DIADERM National Random Sampling Survey. Actas Dermosifiliogr 2023; 114:858-864. [PMID: 37286080 DOI: 10.1016/j.ad.2023.05.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2023] [Revised: 05/22/2023] [Accepted: 05/23/2023] [Indexed: 06/09/2023] Open
Abstract
BACKGROUND Visits for skin conditions are very common in pediatric primary care, and many of the patients seen in outpatient dermatology clinics are children or adolescents. Little, however, has been published about the true prevalence of these visits or about their characteristics. MATERIAL AND METHODS Observational cross-sectional study of diagnoses made in outpatient dermatology clinics during 2 data-collection periods in the anonymous DIADERM National Random Survey of dermatologists across Spain. All entries with an International Classification of Diseases, Tenth Revision code related to dermatology in the 2 periods (84 diagnoses) were collected for patients younger than 18 years and classified into 14 categories to facilitate analysis and comparison. RESULTS In total, the search found 20 097 diagnoses made in patients younger than 18 years (12% of all coded diagnoses in the DIADERM database). Viral infections, acne, and atopic dermatitis were the most common, accounting for 43.9% of all diagnoses. No significant differences were observed in the proportions of diagnoses in the respective caseloads of specialist vs. general dermatology clinics or public vs. private clinics. Seasonal differences in diagnoses (January vs. May) were also nonsignificant. CONCLUSIONS Pediatric care accounts for a significant proportion of the dermatologist's caseload in Spain. Our findings are useful for identifying opportunities for improving communication and training in pediatric primary care and for designing training focused on the optimal treatment of acne and pigmented lesions (with instruction on basic dermoscopy use) in these settings.
Collapse
Affiliation(s)
- A Martin-Gorgojo
- Servicio de ITS/Dermatología, Sección de Especialidades Médicas. Ayuntamiento de Madrid, Madrid, España; Unidad de Investigación. Fundación Piel Sana AEDV, Madrid, España.
| | - J Del Boz
- Unidad de Investigación. Fundación Piel Sana AEDV, Madrid, España; Servicio de Dermatología, Hospital Regional Universitario de Málaga, Málaga, España
| | | | - S Arias-Santiago
- Servicio de Dermatología. Hospital Virgen de las Nieves, Granada, España
| | - A Molina-Leyva
- Servicio de Dermatología. Hospital Virgen de las Nieves, Granada, España
| | - Y Gilaberte
- Servicio de Dermatología. Hospital Universitario Miguel Servet, IIS Aragón, Zaragoza, España
| | - P Fernández-Crehuet
- Servicio de Dermatología. Hospital Universitario Reina Sofía, Córdoba, España
| | - H Husein-ElAhmed
- Servicio de Dermatología. Hospital General de Baza, Granada, España
| | - A Viera-Ramírez
- Servicio de Dermatología. Hospital Santa Catalina, Las Palmas de Gran Canaria, España
| | - P Fernández-Peñas
- The University of Sydney, Department of Dermatology, Westmead Hospital, Westmead, New South Wales, Australia
| | - R Taberner
- Departamento de Dermatología. Hospital de Son Llàtzer, Palma de Mallorca, España
| | | | - I García-Doval
- Unidad de Investigación. Fundación Piel Sana AEDV, Madrid, España
| |
Collapse
|
14
|
Martin-Gorgojo A, García-Doval I, Iglesias-Pena N, Torre EDRDL. [Translated article] Private Dermatology Practice Characteristics and Fees in Spain in 2023: A Survey and Comparison With Findings for 2018. Actas Dermosifiliogr 2023; 114:T899-T903. [PMID: 37734539 DOI: 10.1016/j.ad.2023.09.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2023] [Revised: 03/29/2023] [Accepted: 04/01/2023] [Indexed: 09/23/2023] Open
Abstract
This report analyzes findings from a January 2023 survey of 235 dermatologists in private practice in Spain. The data for 2023 are compared to findings from a similar survey of conditions in 2018, to provide a snapshot of each year and identify changes in clinical practice and adaptations to emerging situations and challenges. Noteworthy changes in 2023 vs. 2018 included increased dedication to private practice and teleconsultations, more use of prepayment for procedures, more acceptance of payment by credit card or other electronic means, and variation in the timing of price changes. Sixty percent of the respondents reported planning to raise prices in 2023. The planned pricing adjustments will approximate the rise in the consumer price index. We also found that male dermatologists more often reported fees at the highest end of the range.
Collapse
Affiliation(s)
| | | | - N Iglesias-Pena
- Servicio de Dermatología, Hospital San Rafael, A Coruña, Spain
| | | |
Collapse
|
15
|
Martin-Gorgojo A, Del Boz J, Descalzo-Gallego MÁ, Arias-Santiago S, Molina-Leyva A, Gilaberte Y, Fernández-Crehuet P, Husein-ElAhmed H, Viera-Ramírez A, Fernández-Peñas P, Taberner R, Buendía-Eisman A, García-Doval I. [Translated article] What Proportion of the Spanish Dermatology Caseload Corresponds to Pediatric Dermatoses? Results From the DIADERM National Random Sampling Survey. Actas Dermosifiliogr 2023; 114:T858-T864. [PMID: 37734543 DOI: 10.1016/j.ad.2023.09.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2023] [Revised: 05/22/2023] [Accepted: 05/23/2023] [Indexed: 09/23/2023] Open
Abstract
BACKGROUND Visits for skin conditions are very common in pediatric primary care, and many of the patients seen in outpatient dermatology clinics are children or adolescents. Little, however, has been published about the true prevalence of these visits or about their characteristics. MATERIAL AND METHODS Observational cross-sectional study of diagnoses made in outpatient dermatology clinics during 2 data-collection periods in the anonymous DIADERM National Random Survey of dermatologists across Spain. All entries with an International Classification of Diseases, Tenth Revision code related to dermatology in the 2 periods (84 diagnoses) were collected for patients younger than 18 years and classified into 14 categories to facilitate analysis and comparison. RESULTS In total, the search found 20 097 diagnoses made in patients younger than 18 years (12% of all coded diagnoses in the DIADERM database). Viral infections, acne, and atopic dermatitis were the most common, accounting for 43.9% of all diagnoses. No significant differences were observed in the proportions of diagnoses in the respective caseloads of specialist vs. general dermatology clinics or public vs. private clinics. Seasonal differences in diagnoses (January vs. May) were also nonsignificant. CONCLUSIONS Pediatric care accounts for a significant proportion of the dermatologist's caseload in Spain. Our findings are useful for identifying opportunities for improving communication and training in pediatric primary care and for designing training focused on the optimal treatment of acne and pigmented lesions (with instruction on basic dermoscopy use) in these settings.
Collapse
Affiliation(s)
- A Martin-Gorgojo
- Servicio de ITS/Dermatología, Sección de Especialidades Médicas. Ayuntamiento de Madrid, Madrid, Spain; Unidad de Investigación. Fundación Piel Sana AEDV, Madrid, Spain.
| | - J Del Boz
- Unidad de Investigación. Fundación Piel Sana AEDV, Madrid, Spain; Servicio de Dermatología, Hospital Regional Universitario de Málaga, Málaga, Spain
| | | | - S Arias-Santiago
- Servicio de Dermatología. Hospital Virgen de las Nieves, Granada, Spain
| | - A Molina-Leyva
- Servicio de Dermatología. Hospital Virgen de las Nieves, Granada, Spain
| | - Y Gilaberte
- Servicio de Dermatología. Hospital Universitario Miguel Servet, IIS Aragón, Zaragoza, Spain
| | - P Fernández-Crehuet
- Servicio de Dermatología. Hospital Universitario Reina Sofía, Córdoba, Spain
| | - H Husein-ElAhmed
- Servicio de Dermatología. Hospital General de Baza, Granada, Spain
| | - A Viera-Ramírez
- Servicio de Dermatología. Hospital Santa Catalina, Las Palmas de Gran Canaria, Spain
| | - P Fernández-Peñas
- The University of Sydney, Department of Dermatology, Westmead Hospital, Westmead, New South Wales, Australia
| | - R Taberner
- Departamento de Dermatología. Hospital de Son Llàtzer, Palma de Mallorca, Spain
| | | | - I García-Doval
- Unidad de Investigación. Fundación Piel Sana AEDV, Madrid, Spain
| |
Collapse
|
16
|
Martin-Gorgojo A, García-Doval I, Iglesias-Pena N, Del Río de la Torre E. Survey on Private Dermatology Practice Characteristics and Fees in Spain in 2023. Update and Changes From 2018. Actas Dermosifiliogr 2023; 114:899-903. [PMID: 37088292 DOI: 10.1016/j.ad.2023.04.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2023] [Revised: 03/29/2023] [Accepted: 04/01/2023] [Indexed: 04/25/2023] Open
Abstract
The present work includes the analysis of the data obtained through a survey conducted in January 2023 to 235 dermatologists practicing private healthcare activity in Spain. A subsequent frame is added to the study with similar methodology carried out in 2018, while analyzing the changes and adaptations that the practice has with the new times and emerging challenges. Compared to 2018, in 2023 the following findings stand out: increases in dedication to private activity, teleconsultations, advance payment for techniques, acceptance of payments by bank card and electronic banking; changes in the periodicity of price adjustment; the fact that 60% of respondents state that they have adjusted prices upwards in the year; a rise in prices that is approximately in line with that of the CPI, and the observation that male dermatologists more frequently state higher extreme prices.
Collapse
Affiliation(s)
| | | | - N Iglesias-Pena
- Servicio de Dermatología, Hospital San Rafael, A Coruña, España
| | | |
Collapse
|
17
|
Pulido-Pérez A, Descalzo-Gallego MA, Arias-Santiago S, Molina-Leyva A, Gilaberte Y, Fernández-Crehuet P, Husein-ElAhmed H, Viera-Ramírez A, Fernández-Peñas P, Taberner R, Buendía-Eisman A, García-Doval I. Nonvenereal Infections in Spanish Dermatology Clinics: Results of the DIADERM Study. Actas Dermosifiliogr 2023:S0001-7310(23)00351-4. [PMID: 37172892 DOI: 10.1016/j.ad.2023.05.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2023] [Accepted: 03/16/2023] [Indexed: 05/15/2023] Open
Abstract
BACKGROUND AND OBJECTIVE The burden of nonvenereal infections in Spanish dermatology practice has not yet been evaluated. The aim of this study was to analyze the overall weight of these infections in outpatient dermatology caseloads. MATERIAL AND METHODS Observational cross-sectional study of diagnoses made by a random selection of dermatologists from the Spanish Association of Dermatology and Venereology (AEDV) working in outpatient dermatology clinics. The data were obtained through the anonymous DIADERM survey. Diagnoses of infectious diseases were selected using codes from the International Classification of Diseases, Tenth Revision. After excluding sexually transmitted infections, the diagnoses were classified into 22 groups. RESULTS Spanish dermatologists diagnosed an estimated 16 190 (95% CI, 9338-23 042) nonvenereal infections on average per week, a figure that accounted for 9.33% of the dermatology caseload. The most common diagnostic groups were nonanogenital viral warts (7475 diagnoses, 46.17% of nonvenereal infections), dermatophytosis (3336, 20.61%), and other viral infections (1592, 9.84%), which included Molluscum contagiosum infections. Nonvenereal infections were more common than noninfectious dermatologic conditions in private clinics (P < .0020) and adults (P <.00001). Patients with these infections were also more likely to be discharged than those with other conditions in both public (P < .0004) and private (P < .0002) practices. CONCLUSIONS Nonvenereal infections are frequent in dermatology. They are the third most common reason for outpatient visits, behind actinic keratosis and nonmelanoma skin cancer. By enhancing the participation of dermatologists in the management of skin infections and encouraging interactions with other specialists, we will be able to carve out a niche in an area we have scarcely ventured into to date.
Collapse
Affiliation(s)
- A Pulido-Pérez
- Servicio de Dermatología, Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, España.
| | - M A Descalzo-Gallego
- Unidad de Investigación, Academia Española de Dermatología y Venereología, Madrid, España
| | - S Arias-Santiago
- Servicio de Dermatología, Hospital Virgen de las Nieves, Granada, España. Instituto de investigación Biosanitaria ibsGranada, España
| | - A Molina-Leyva
- Servicio de Dermatología, Hospital Virgen de las Nieves, Granada, España. Instituto de investigación Biosanitaria ibsGranada, España
| | - Y Gilaberte
- Servicio de Dermatología, Hospital Universitario Miguel Servet, IIS Aragón, Zaragoza, España
| | - P Fernández-Crehuet
- Servicio de Dermatología. Hospital Universitario Reina Sofía, Córdoba, España
| | - H Husein-ElAhmed
- Servicio de Dermatología, Hospital General de Baza, Baza, Granada, España
| | - A Viera-Ramírez
- Servicio de Dermatología, Hospital Santa Catalina, Las Palmas de Gran Canaria, España
| | - P Fernández-Peñas
- Department of Dermatology, Westmead Hospital, The University of Sydney, Westmead, New South Wales, Australia
| | - R Taberner
- Departamento de Dermatología, Hospital de Son Llàtzer, Palma de Mallorca, España
| | | | - I García-Doval
- Unidad de Investigación, Academia Española de Dermatología y Venereología, Madrid, España
| |
Collapse
|
18
|
Munera-Campos M, Chicharro P, Gonzalez Quesada A, Florez Menendez A, de la Cueva Dovao P, Gimenez Arnau AM, Gilaberte Calzada Y, Rodríguez Serna M, Montero T, Silvestre Salvador JF, Elosua González M, Del Alcazar E, Santamaría C, Sánchez-Pérez J, Carretero Hernández G, Batalla Cebey A, Jin Suh Oh H, Mauleón Fernández C, Curto Barredo L, Bertolín M, Navarro Bielsa A, Ballano Ruiz A, Botella Estrada R, Arias Santiago S, Betlloch I, Roustan Gullón G, Rosell Díaz A, Descalzo MÁ, García-Doval I, Carrascosa JM. [[Translated article]]BIOBADATOP Spanish Atopic Dermatitis Registry: Description and Early Findings. Actas Dermosifiliogr 2023:S0001-7310(23)00349-6. [PMID: 37172898 DOI: 10.1016/j.ad.2023.05.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2023] [Accepted: 03/07/2023] [Indexed: 05/15/2023] Open
Abstract
BACKGROUND In recent years, remarkable improvements in our understanding of atopic dermatitis (AD) have revolutionized treatment perspectives, but access to reliable data from clinical practice is essential. MATERIALS AND METHOD The Spanish Atopic Dermatitis Registry, BIOBADATOP, is a prospective, multicenter database that collects information on patients of all ages with AD requiring systemic therapy with conventional or novel drugs. We analyzed the registry to describe patient characteristics, diagnoses, treatments, and adverse events (AEs). RESULTS We studied data entries for 258 patients who had received 347 systemic treatments for AD. Treatment was discontinued in 29.4% of cases, mostly due to a lack of effectiveness (in 10.7% of cases). A total of 132 AEs were described during follow-up. Eighty-six AEs (65%) were linked to a systemic treatment, most commonly dupilumab (39 AEs) and cyclosporine (38 AEs). The most common AEs were conjunctivitis (11 patients), headache (6), hypertrichosis (5), and nausea (4). There was 1 severe AE (acute mastoiditis) associated with cyclosporine. CONCLUSIONS Initial findings on AEs from the Spanish BIOBADATOP registry are limited by short follow-up times precluding comparisons or calculation of crude and adjusted incidence rates. At the time of our analysis, no severe AEs had been reported for novel systemic therapies. BIOBADATOP will help answer questions on the effectiveness and safety of conventional and novel systemic therapies in AD.
Collapse
Affiliation(s)
- M Munera-Campos
- Servicio de Dermatología. Hospital Universitari Germans Trias i Pujol. Universitat Autònoma de Barcelona. Germans Trias i Pujol Research Institute (IGTP). Badalona, Barcelona, Spain.
| | - P Chicharro
- Servicio de Dermatología. Hospital Universitario de la Princesa, Madrid, Spain
| | - A Gonzalez Quesada
- Servicio de Dermatología. Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain
| | - A Florez Menendez
- Servicio de Dermatología. Complejo Hospitalario de Pontevedra, Pontevedra, Spain
| | - P de la Cueva Dovao
- Servicio de Dermatología. Hospital Universitario Infanta Leonor, Madrid, Spain
| | - A M Gimenez Arnau
- Servicio de Dermatología. Hospital del Mar-Parc de Salut Mar, Barcelona, Spain
| | - Y Gilaberte Calzada
- Servicio de Dermatología. Hospital Universitario Miguel Servet, Zaragoza, Spain
| | - M Rodríguez Serna
- Servicio de Dermatología. Hospital Universitario y Politécnico la Fe, Valencia, Spain
| | - T Montero
- Servicio de Dermatología. Hospital Universitario Virgen de las Nieves, Granada, Spain
| | | | - M Elosua González
- Servicio de Dermatología. Hospital Universitario Puerta de Hierro, Madrid, Spain
| | - E Del Alcazar
- Servicio de Dermatología. Hospital Universitari Germans Trias i Pujol. Universitat Autònoma de Barcelona. Germans Trias i Pujol Research Institute (IGTP). Badalona, Barcelona, Spain
| | - C Santamaría
- Servicio de Dermatología. Hospital Universitario de la Princesa, Madrid, Spain
| | - J Sánchez-Pérez
- Servicio de Dermatología. Hospital Universitario de la Princesa, Madrid, Spain
| | - G Carretero Hernández
- Servicio de Dermatología. Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain
| | - A Batalla Cebey
- Servicio de Dermatología. Complejo Hospitalario de Pontevedra, Pontevedra, Spain
| | - H Jin Suh Oh
- Servicio de Dermatología. Complejo Hospitalario de Pontevedra, Pontevedra, Spain
| | - C Mauleón Fernández
- Servicio de Dermatología. Hospital Universitario Infanta Leonor, Madrid, Spain
| | - L Curto Barredo
- Servicio de Dermatología. Hospital del Mar-Parc de Salut Mar, Barcelona, Spain
| | - M Bertolín
- Servicio de Dermatología. Hospital del Mar-Parc de Salut Mar, Barcelona, Spain
| | - A Navarro Bielsa
- Servicio de Dermatología. Hospital Universitario Miguel Servet, Zaragoza, Spain
| | - A Ballano Ruiz
- Servicio de Dermatología. Hospital Universitario Miguel Servet, Zaragoza, Spain
| | - R Botella Estrada
- Servicio de Dermatología. Hospital Universitario y Politécnico la Fe, Valencia, Spain
| | - S Arias Santiago
- Servicio de Dermatología. Hospital Universitario Virgen de las Nieves, Granada, Spain
| | - I Betlloch
- Servicio de Dermatología. Hospital General Universitario Alicante, Alicante, Spain
| | - G Roustan Gullón
- Servicio de Dermatología. Hospital Universitario Puerta de Hierro, Madrid, Spain
| | - A Rosell Díaz
- Servicio de Dermatología. Hospital Universitario Puerta de Hierro, Madrid, Spain
| | - M Á Descalzo
- Unidad de Investigación. Fundación Piel Sana AEDV, Spain
| | - I García-Doval
- Unidad de Investigación. Fundación Piel Sana AEDV, Spain; Servicio de Dermatología. Complexo Hospitalario Universitario de Vigo, Vigo, Spain
| | - J M Carrascosa
- Servicio de Dermatología. Hospital Universitari Germans Trias i Pujol. Universitat Autònoma de Barcelona. Germans Trias i Pujol Research Institute (IGTP). Badalona, Barcelona, Spain
| |
Collapse
|
19
|
Pulido-Pérez A, Descalzo-Gallego MA, Arias-Santiago S, Molina-Leyva A, Gilaberte Y, Fernández-Crehuet P, Husein-ElAhmed H, Viera-Ramírez A, Fernández-Peñas P, Taberner R, Buendía-Eisman A, García-Doval I. Nonvenereal Infections in Spanish Dermatology Clinics: Results of the DIADERM Study. Actas Dermosifiliogr 2023:S0001-7310(23)00222-3. [PMID: 36965772 DOI: 10.1016/j.ad.2023.03.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2023] [Revised: 03/13/2023] [Accepted: 03/16/2023] [Indexed: 03/27/2023] Open
Abstract
BACKGROUND AND OBJECTIVE The burden of nonvenereal infections in Spanish dermatology practice has not yet been evaluated. The aim of this study was to analyze the overall weight of these infections in outpatient dermatology caseloads. MATERIAL AND METHODS Observational cross-sectional study of diagnoses made by a random selection of dermatologists from the Spanish Association of Dermatology and Venereology (AEDV) working in outpatient dermatology clinics. The data were obtained through the anonymous DIADERM survey. Diagnoses of infectious diseases were selected using codes from the International Classification of Diseases, Tenth Revision. After excluding sexually transmitted infections, the diagnoses were classified into 22 groups. RESULTS Spanish dermatologists diagnosed an estimated 16 190 (95% CI, 9338-23 042) nonvenereal infections on average per week, a figure that accounted for 9.33% of the dermatology caseload. The most common diagnostic groups were nonanogenital viral warts (7475 diagnoses, 46.17% of nonvenereal infections), dermatophytosis (3336, 20.61%), and other viral infections (1592, 9.84%), which included Molluscum contagiosum infections. Nonvenereal infections were more common than noninfectious dermatologic conditions in private clinics (P < .0020) and adults (P <.00001). Patients with these infections were also more likely to be discharged than those with other conditions in both public (P < .0004) and private (P < .0002) practices. CONCLUSIONS Nonvenereal infections are frequent in dermatology. They are the third most common reason for outpatient visits, behind actinic keratosis and nonmelanoma skin cancer. By enhancing the participation of dermatologists in the management of skin infections and encouraging interactions with other specialists, we will be able to carve out a niche in an area we have scarcely ventured into to date.
Collapse
Affiliation(s)
- A Pulido-Pérez
- Servicio de Dermatología, Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, España.
| | - M A Descalzo-Gallego
- Unidad de Investigación, Academia Española de Dermatología y Venereología, Madrid, España
| | - S Arias-Santiago
- Servicio de Dermatología, Hospital Virgen de las Nieves, Granada, España. Instituto de investigación Biosanitaria ibsGranada, España
| | - A Molina-Leyva
- Servicio de Dermatología, Hospital Virgen de las Nieves, Granada, España. Instituto de investigación Biosanitaria ibsGranada, España
| | - Y Gilaberte
- Servicio de Dermatología, Hospital Universitario Miguel Servet, IIS Aragón, Zaragoza, España
| | - P Fernández-Crehuet
- Servicio de Dermatología. Hospital Universitario Reina Sofía, Córdoba, España
| | - H Husein-ElAhmed
- Servicio de Dermatología, Hospital General de Baza, Baza, Granada, España
| | - A Viera-Ramírez
- Servicio de Dermatología, Hospital Santa Catalina, Las Palmas de Gran Canaria, España
| | - P Fernández-Peñas
- Department of Dermatology, Westmead Hospital, The University of Sydney, Westmead, New South Wales, Australia
| | - R Taberner
- Departamento de Dermatología, Hospital de Son Llàtzer, Palma de Mallorca, España
| | | | - I García-Doval
- Unidad de Investigación, Academia Española de Dermatología y Venereología, Madrid, España
| |
Collapse
|
20
|
Munera-Campos M, Chicharro P, Gonzalez Quesada A, Florez Menendez A, de la Cueva Dovao P, Gimenez Arnau AM, Gilaberte Calzada Y, Rodríguez Serna M, Montero T, Silvestre Salvador JF, Elosua González M, Del Alcazar E, Santamaría C, Sánchez-Pérez J, Carretero Hernández G, Batalla Cebey A, Jin Suh Oh H, Mauleón Fernández C, Curto Barredo L, Bertolín M, Navarro Bielsa A, Ballano Ruiz A, Botella Estrada R, Arias Santiago S, Betlloch I, Roustan Gullón G, Rosell Díaz A, Descalzo MÁ, García-Doval I, Carrascosa JM. BIOBADATOP Spanish Atopic Dermatitis Registry: Description and Early Findings. Actas Dermosifiliogr 2023:S0001-7310(23)00181-3. [PMID: 36935039 DOI: 10.1016/j.ad.2023.03.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2023] [Accepted: 03/07/2023] [Indexed: 03/19/2023] Open
Abstract
BACKGROUND In recent years, remarkable improvements in our understanding of atopic dermatitis (AD) have revolutionized treatment perspectives, but access to reliable data from clinical practice is essential. MATERIALS AND METHOD The Spanish Atopic Dermatitis Registry, BIOBADATOP, is a prospective, multicenter database that collects information on patients of all ages with AD requiring systemic therapy with conventional or novel drugs. We analyzed the registry to describe patient characteristics, diagnoses, treatments, and adverse events (AEs). RESULTS We studied data entries for 258 patients who had received 347 systemic treatments for AD. Treatment was discontinued in 29.4% of cases, mostly due to a lack of effectiveness (in 10.7% of cases). A total of 132 AEs were described during follow-up. Eighty-six AEs (65%) were linked to a systemic treatment, most commonly dupilumab (39 AEs) and cyclosporine (38 AEs). The most common AEs were conjunctivitis (11 patients), headache (6), hypertrichosis (5), and nausea (4). There was 1 severe AE (acute mastoiditis) associated with cyclosporine. CONCLUSIONS Initial findings on AEs from the Spanish BIOBADATOP registry are limited by short follow-up times precluding comparisons or calculation of crude and adjusted incidence rates. At the time of our analysis, no severe AEs had been reported for novel systemic therapies. BIOBADATOP will help answer questions on the effectiveness and safety of conventional and novel systemic therapies in AD.
Collapse
Affiliation(s)
- M Munera-Campos
- Servicio de Dermatología. Hospital Universitari Germans Trias i Pujol. Universitat Autònoma de Barcelona. Germans Trias i Pujol Research Institute (IGTP). Badalona, Barcelona, Spain.
| | - P Chicharro
- Servicio de Dermatología. Hospital Universitario de la Princesa, Madrid, Spain
| | - A Gonzalez Quesada
- Servicio de Dermatología. Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain
| | - A Florez Menendez
- Servicio de Dermatología. Complejo Hospitalario de Pontevedra, Pontevedra, Spain
| | - P de la Cueva Dovao
- Servicio de Dermatología. Hospital Universitario Infanta Leonor, Madrid, Spain
| | - A M Gimenez Arnau
- Servicio de Dermatología. Hospital del Mar-Parc de Salut Mar, Barcelona, Spain
| | - Y Gilaberte Calzada
- Servicio de Dermatología. Hospital Universitario Miguel Servet, Zaragoza, Spain
| | - M Rodríguez Serna
- Servicio de Dermatología. Hospital Universitario y Politécnico la Fe, Valencia, Spain
| | - T Montero
- Servicio de Dermatología. Hospital Universitario Virgen de las Nieves, Granada, Spain
| | | | - M Elosua González
- Servicio de Dermatología. Hospital Universitario Puerta de Hierro, Madrid, Spain
| | - E Del Alcazar
- Servicio de Dermatología. Hospital Universitari Germans Trias i Pujol. Universitat Autònoma de Barcelona. Germans Trias i Pujol Research Institute (IGTP). Badalona, Barcelona, Spain
| | - C Santamaría
- Servicio de Dermatología. Hospital Universitario de la Princesa, Madrid, Spain
| | - J Sánchez-Pérez
- Servicio de Dermatología. Hospital Universitario de la Princesa, Madrid, Spain
| | - G Carretero Hernández
- Servicio de Dermatología. Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain
| | - A Batalla Cebey
- Servicio de Dermatología. Complejo Hospitalario de Pontevedra, Pontevedra, Spain
| | - H Jin Suh Oh
- Servicio de Dermatología. Complejo Hospitalario de Pontevedra, Pontevedra, Spain
| | - C Mauleón Fernández
- Servicio de Dermatología. Hospital Universitario Infanta Leonor, Madrid, Spain
| | - L Curto Barredo
- Servicio de Dermatología. Hospital del Mar-Parc de Salut Mar, Barcelona, Spain
| | - M Bertolín
- Servicio de Dermatología. Hospital del Mar-Parc de Salut Mar, Barcelona, Spain
| | - A Navarro Bielsa
- Servicio de Dermatología. Hospital Universitario Miguel Servet, Zaragoza, Spain
| | - A Ballano Ruiz
- Servicio de Dermatología. Hospital Universitario Miguel Servet, Zaragoza, Spain
| | - R Botella Estrada
- Servicio de Dermatología. Hospital Universitario y Politécnico la Fe, Valencia, Spain
| | - S Arias Santiago
- Servicio de Dermatología. Hospital Universitario Virgen de las Nieves, Granada, Spain
| | - I Betlloch
- Servicio de Dermatología. Hospital General Universitario Alicante, Alicante, Spain
| | - G Roustan Gullón
- Servicio de Dermatología. Hospital Universitario Puerta de Hierro, Madrid, Spain
| | - A Rosell Díaz
- Servicio de Dermatología. Hospital Universitario Puerta de Hierro, Madrid, Spain
| | - M Á Descalzo
- Unidad de Investigación. Fundación Piel Sana AEDV, Spain
| | - I García-Doval
- Unidad de Investigación. Fundación Piel Sana AEDV, Spain; Servicio de Dermatología. Complexo Hospitalario Universitario de Vigo, Vigo, Spain
| | - J M Carrascosa
- Servicio de Dermatología. Hospital Universitari Germans Trias i Pujol. Universitat Autònoma de Barcelona. Germans Trias i Pujol Research Institute (IGTP). Badalona, Barcelona, Spain
| |
Collapse
|
21
|
Martin-Gorgojo A, García-Doval I, Buendía-Eisman A, Nagore E. [Translated article] Analysis of Undergraduate Dermatology Syllabi at Spanish Universities: Does the Weight of Theoretical Content Match the Skin Conditions Seen in Primary Care and General Dermatology Practices? Actas Dermosifiliogr 2023; 114:T194-T212. [PMID: 36690144 DOI: 10.1016/j.ad.2022.10.041] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2022] [Accepted: 10/24/2022] [Indexed: 01/22/2023] Open
Abstract
INTRODUCTION Undergraduate dermatology courses vary in the nearly 50 Spanish medical faculties that teach the subject. This study aimed to describe the characteristics of these courses and to analyze whether the weight assigned to dermatology topics reflects the caseloads of primary care physicians and general dermatologists in the Spanish national health system. MATERIAL AND METHODS Cross-sectional study of syllabi used in Spanish medical faculties during the 2021-2022 academic year. We determined the number of teaching hours in public and private university curricula and compared the weight of dermatology topics covered to the dermatology caseloads of primary care physicians and general dermatologists as reported in published studies. RESULTS Most medical faculties taught dermatology for one semester. The median number of credits offered was 4.5. On average, lectures covered 24 theoretical topics, and seminars and workshops covered 9 topics. We identified a clear disparity between the percentage of time devoted to dermatology topics in course lectures and the skin conditions usually managed in primary care and general dermatology practices. DISCUSSION The skin diseases most commonly treated by primary care physicians and general dermatologists are underrepresented in the curricula of Spanish medical faculties. The topics that should be given more weight in syllabi, or recovered for inclusion in dermatology courses, should be re-examined. Our findings show that the topics that ideally should be emphasized more are types of dermatitis, infectious skin diseases, acne, psoriasis, rashes, and the differential diagnosis of benign and malignant neoplasms. There should be additional support for the theoretical teaching of these topics.
Collapse
Affiliation(s)
- A Martin-Gorgojo
- Sección Especialidades Médicas, Servicio ITS/Dermatología, Organismo Autónomo Madrid Salud, Ayuntamiento de Madrid, Madrid, Spain.
| | - I García-Doval
- Unidad de Investigación, Fundación Piel Sana AEDV, Madrid, Spain; Servicio de Dermatología, Complexo Hospitalario Universitario de Vigo, Vigo, Pontevedra, Spain
| | | | - E Nagore
- Departamento de Dermatología, Universidad Católica de Valencia San Vicente Mártir. Servicio de Dermatología, Fundación Instituto Valenciano de Oncología, Facultad de Medicina, Universidad Católica de Valencia San Vicente Mártir, Valencia, Spain
| |
Collapse
|
22
|
Martin-Gorgojo A, García-Doval I, Buendía-Eisman A, Nagore E. Analysis of Undergraduate Dermatology Syllabi at Spanish Universities: Does the Weight of Theoretical Content Match the Skin Conditions Seen in Primary Care and General Dermatology Practices? Actas Dermosifiliogr 2023; 114:194-212. [PMID: 36370834 DOI: 10.1016/j.ad.2022.10.038] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2022] [Revised: 10/19/2022] [Accepted: 10/24/2022] [Indexed: 11/11/2022] Open
Abstract
INTRODUCTION Undergraduate dermatology courses vary in the nearly 50 Spanish medical faculties that teach the subject. This study aimed to describe the characteristics of these courses and to analyze whether the weight assigned to dermatology topics reflect the caseloads of primary care physicians and general dermatologists in the Spanish national health system. MATERIAL AND METHODS Cross-sectional study of syllabi used in Spanish medical faculties during the 2021-2022 academic year. We determined the number of teaching hours in public and private university curricula and compared the weight of dermatology topics covered to the dermatology caseloads of primary care physicians and general dermatologists as reported in published studies. RESULTS Most medical faculties taught dermatology for one semester. The median number of credits offered was 4.5. On average, lectures covered 24 theoretical topics, and seminars and workshops covered 9 topics. We identified a clear disparity between the percentage of time devoted to dermatology topics in course lectures and the skin conditions usually managed in primary care and general dermatology practices. DISCUSSION The skin diseases most commonly treated by primary care physicians and general dermatologists are underrepresented in the curricula of Spanish medical faculties. The topics that should be given more weight in syllabi, or recovered for inclusion in dermatology courses, should be re-examined. Our findings show that the topics that ideally should be emphasized more are types of dermatitis, infectious skin diseases, acne, psoriasis, rashes, and the differential diagnosis of benign and malignant neoplasms. There should be additional support for the theoretical teaching of these topics.
Collapse
Affiliation(s)
- A Martin-Gorgojo
- Sección Especialidades Médicas, Servicio ITS/Dermatología, Organismo Autónomo Madrid Salud, Ayuntamiento de Madrid, Madrid, España.
| | - I García-Doval
- Unidad de Investigación, Fundación Piel Sana AEDV, Madrid, España; Servicio de Dermatología, Complexo Hospitalario Universitario de Vigo, Vigo, Pontevedra, España
| | | | - E Nagore
- Departamento de Dermatología, Universidad Católica de Valencia San Vicente Mártir. Servicio de Dermatología, Fundación Instituto Valenciano de Oncología, Facultad de Medicina, Universidad Católica de Valencia San Vicente Mártir, Valencia, España
| |
Collapse
|
23
|
Falkenhain-López D, Muniesa C, Estrach MT, Morillo-Andújar M, Peñate Y, Acebo E, Pujol RM, García-Muret MP, Machan S, Medina S, Botella-Estrada R, Fernández de Misa R, Blanes M, Flórez A, Pérez-Paredes G, Izu R, Yanguas I, Silva-Díaz E, Pérez-Ferriols A, Prieto-Torres L, Zayas A, Parera-Amer ME, Pérez A, Aspe L, Román C, Sánchez-Caminero MP, Bassas-Vila J, Domínguez-Auñón JD, Calzado L, Navedo M, Ortiz-Prieto A, Servitje O, Polo-Rodríguez I, Torres I, Hernández-Hernández MN, Mitxelena-Eceiza J, García-Vázquez A, García-Doval I, Ortiz-Romero PL. [Translated article] Primary Cutaneous Lymphoma Registry of the Spanish Academy of Dermatology and Venereology (AEDV): Data for the First 5 Years. Actas Dermosifiliogr 2023; 114:T291-T298. [PMID: 36848951 DOI: 10.1016/j.ad.2022.11.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2022] [Accepted: 11/12/2022] [Indexed: 02/27/2023] Open
Abstract
BACKGROUND AND OBJECTIVE Primary cutaneous lymphomas (PCL) are uncommon. Observations based on the first year of data from the Spanish Registry of Primary Cutaneous Lymphomas (RELCP, in its Spanish abbreviation) of the Spanish Academy of Dermatology and Venereology (AEDV) were published in February 2018. This report covers RELCP data for the first 5 years. PATIENTS AND METHODS RELCP data were collected prospectively and included diagnosis, treatments, tests, and the current status of patients. We compiled descriptive statistics of the data registered during the first 5 years. RESULTS Information on 2020 patients treated at 33 Spanish hospitals had been included in the RELCP by December 2021. Fifty-nine percent of the patients were men; the mean age was 62.2 years. The lymphomas were grouped into 4 large diagnostic categories: mycosis fungoides/Sézary syndrome, 1112 patients (55%); primary B-cell cutaneous lymphoma, 547 patients (27.1%); primary CD30+ lymphoproliferative disorders, 222 patients (11%), and other T-cell lymphomas, 116 patients (5.8%). Nearly 75% of the tumors were registered in stage I. After treatment, 43.5% achieved complete remission and 27% were stable at the time of writing. Treatments prescribed were topical corticosteroids (1369 [67.8%]), phototherapy (890 patients [44.1%]), surgery (412 patients [20.4%]), and radiotherapy (384 patients [19%]). CONCLUSION The characteristics of cutaneous lymphomas in Spain are similar to those reported for other series. The large size of the RELCP registry at 5 years has allowed us to give more precise descriptive statistics than in the first year. This registry facilitates the clinical research of the AEDV's lymphoma interest group, which has already published articles based on the RELCP data.
Collapse
Affiliation(s)
- D Falkenhain-López
- Departamento de Dermatología, Hospital Universitario 12 de Octubre, Madrid, Spain.
| | - C Muniesa
- Departamento de Dermatología, Hospital Universitari de Bellvitge, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain
| | - M T Estrach
- Departamento de Dermatología, Hospital Clínico, IDIBAPS, Universitario de Barcelona, Barcelona, Spain
| | - M Morillo-Andújar
- Departamento de Dermatología, Hospital Virgen del Rocío, Sevilla, Spain
| | - Y Peñate
- Departamento de Dermatología, Complejo Hospitalario Universitario Insular Materno-Infantil, Gran Canaria, Spain
| | - E Acebo
- Departamento de Dermatología, Hospital Universitario de Cruces, Barakaldo, Bizkaia, Spain
| | - R M Pujol
- Departamento de Dermatología, Hospital del Mar, Barcelona, Spain
| | - M P García-Muret
- Departamento de Dermatología, Hospital Santa Creu i Sant Pau, UAB Barcelona, Barcelona, Spain
| | - S Machan
- Departamento de Dermatología, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
| | - S Medina
- Departamento de Dermatología, Hospital Universitario Príncipe de Asturias, Madrid, Spain
| | - R Botella-Estrada
- Departamento de Dermatología, Hospital Universitario La Fe, Valencia, Spain
| | - R Fernández de Misa
- Departamento de Dermatología, Hospital Universitario Nuestra Señora de la Candelaria, Tenerife, Spain
| | - M Blanes
- Departamento de Dermatología, Hospital General Universitario de Alicante, Alicante, Spain
| | - A Flórez
- Departamento de Dermatología, Complejo Hospitalario Universitario de Pontevedra, Pontevedra, Spain
| | - G Pérez-Paredes
- Departamento de Dermatología, Hospital Universitario Marqués de Valdecilla, Santander Cantabria, Spain
| | - R Izu
- Departamento de Dermatología, Hospital Universitario de Basurto, Bilbao, Bizkaia, Spain
| | - I Yanguas
- Departamento de Dermatología Complejo Hospitalario de Navarra, Navarra, Spain
| | - E Silva-Díaz
- Departamento de Dermatología, Hospital Clínico Universitario de Valencia, Valencia, Spain
| | - A Pérez-Ferriols
- Departamento de Dermatología, Hospital General Universitario de Valencia, Valencia, Spain
| | - L Prieto-Torres
- Departamento de Dermatología, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain
| | - A Zayas
- Departamento de Dermatología, Hospital Universitario Dr. Peset, Valencia, Spain
| | - M E Parera-Amer
- Departamento de Dermatología, Hospital Universitario Son Llàtzer, Palma, Islas Baleares, Spain
| | - A Pérez
- Departamento de Dermatología, Hospital Universitario Nuestra Señora De Valme, Sevilla, Spain
| | - L Aspe
- Departamento de Dermatología, Hospital Universitario de Araba, Vitoria-Gasteiz, Álava, Spain
| | - C Román
- Departamento de Dermatología, Hospital Universitario de Salamanca, Salamanca, Spain
| | - M P Sánchez-Caminero
- Departamento de Dermatología, Hospital General de Ciudad Real, Ciudad Real, Spain
| | - J Bassas-Vila
- Departamento de Dermatología, Hospital Germans Trias i Pujol, Barcelona, Spain
| | - J D Domínguez-Auñón
- Departamento de Dermatología, Hospital Universitario del Henares, Coslada, Madrid, Spain
| | - L Calzado
- Departamento de Dermatología, Hospital Universitario de Torrejón, Torrejón de Ardoz, Madrid, Spain
| | - M Navedo
- Departamento de Dermatología, Complejo Asistencial Universitario de León, León, Spain
| | - A Ortiz-Prieto
- Departamento de Dermatología, Hospital Puerta del Mar, Cádiz, Spain
| | - O Servitje
- Departamento de Dermatología, Hospital Universitari de Bellvitge, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain
| | - I Polo-Rodríguez
- Departamento de Dermatología, Hospital Universitario Príncipe de Asturias, Madrid, Spain
| | - I Torres
- Departamento de Dermatología, Hospital Universitario La Fe, Valencia, Spain
| | - M N Hernández-Hernández
- Departamento de Dermatología, Hospital Universitario Nuestra Señora de la Candelaria, Tenerife, Spain
| | - J Mitxelena-Eceiza
- Departamento de Dermatología Complejo Hospitalario de Navarra, Navarra, Spain
| | - A García-Vázquez
- Departamento de Dermatología, Hospital Clínico Universitario de Valencia, Valencia, Spain
| | - I García-Doval
- Unidad de Investigación, Fundación Piel Sana AEDV, León, Spain; Departamento de Dermatología, Complejo Hospitalario Universitario de Vigo, Vigo, Pontevedra, Spain
| | - P L Ortiz-Romero
- Departamento de Dermatología, Hospital Universitario 12 de Octubre, Madrid, Spain
| |
Collapse
|
24
|
Rivera-Diaz R, Carretero G, Carrascosa JM, García-Doval I. Erythrodermic Psoriasis Has Become Less Frequent: Results From the Biobadaderm Registry. Actas Dermosifiliogr 2023; 114:T366-T369. [PMID: 36738778 DOI: 10.1016/j.ad.2022.12.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2022] [Accepted: 12/07/2022] [Indexed: 02/05/2023] Open
Affiliation(s)
- R Rivera-Diaz
- Servicio de Dermatología, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, España.
| | - G Carretero
- Servicio de Dermatología, Hospital Universitario Doctor Negrín, Gran Canaria, España
| | - J M Carrascosa
- Servicio de Dermatología, Hospital Universitario Germans Trias i Pujol, Barcelona, España
| | - I García-Doval
- Unidad de investigación de la Academia Española de Dermatología y Venereología, Fundación Piel sana, Servicio de Dermatología, Complejo Hospitalario Universitario, Vigo, España
| |
Collapse
|
25
|
Martin-Gorgojo A, Del Río-de la Torre E, García-Doval I. Safety in Dermatologic Procedures: An Article Series to Improve Safety in Dermatologic Care. Actas Dermosifiliogr 2023; 114:95-96. [PMID: 35753361 DOI: 10.1016/j.ad.2022.05.023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2022] [Accepted: 05/22/2022] [Indexed: 01/11/2023] Open
Affiliation(s)
- A Martin-Gorgojo
- Servicio de ITS/Dermatología, Sección de Especialidades Médicas, Ayuntamiento de Madrid, Madrid, España.
| | | | - I García-Doval
- Servicio de Dermatología, Complexo Hospitalario Universitario de Vigo, Vigo, Pontevedra, España
| |
Collapse
|
26
|
Rivera-Diaz R, Carretero G, Carrascosa JM, García-Doval I. Erythrodermic Psoriasis Has Become Less Frequent: Results From the Biobadaderm Registry. Actas Dermosifiliogr 2022; 114:366-369. [PMID: 36563780 DOI: 10.1016/j.ad.2022.12.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2022] [Accepted: 12/07/2022] [Indexed: 12/24/2022] Open
Affiliation(s)
- R Rivera-Diaz
- Dermatology Department, University Hospital 12 de Octubre & Universidad Complutense, Madrid, Spain.
| | - G Carretero
- Dermatology Department, Universitary Hospital Gran Canaria Doctor Negrin, Gran Canaria, Spain
| | | | - I García-Doval
- Academia Española de Dermatología y Venereología, Research Unit, Fundación Piel Sana & Complexo Hospitalario Universitario de Vigo, Servicio de Dermatologia, Spain
| |
Collapse
|
27
|
Falkenhain-López D, Muniesa C, Estrach MT, Morillo-Andújar M, Peñate Y, Acebo E, Pujol RM, García-Muret MP, Machan S, Medina S, Botella-Estrada R, Fernández de Misa R, Blanes M, Flórez A, Pérez-Paredes G, Izu R, Yanguas I, Silva-Díaz E, Pérez-Ferriols A, Prieto-Torres L, Zayas A, Parera-Amer ME, Pérez A, Aspe L, Román C, Sánchez-Caminero MP, Bassas-Vila J, Domínguez-Auñón JD, Calzado L, Navedo M, Ortiz-Prieto A, Servitje O, Polo-Rodríguez I, Torres I, Hernández-Hernández MN, Mitxelena-Eceiza J, García-Vázquez A, García-Doval I, Ortiz-Romero PL. Primary Cutaneous Lymphoma Registry of the Spanish Academy of Dermatology and Venereology (AEDV): Data for the First 5 Years. Actas Dermosifiliogr 2022; 114:291-298. [PMID: 36529273 DOI: 10.1016/j.ad.2022.11.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2022] [Revised: 11/09/2022] [Accepted: 11/12/2022] [Indexed: 12/23/2022] Open
Abstract
BACKGROUND AND OBJECTIVE Primary cutaneous lymphomas (PCL) are uncommon. Observations based on the first year of data from the Spanish Registry of Primary Cutaneous Lymphomas (RELCP, in its Spanish abbreviation) of the Spanish Academy of Dermatology and Venereology (AEDV) were published in February 2018. This report covers RELCP data for the first 5 years. PATIENTS AND METHODS RELCP data were collected prospectively and included diagnosis, treatments, tests, and the current status of patients. We compiled descriptive statistics of the data registered during the first 5 years. RESULTS Information on 2020 patients treated at 33 Spanish hospitals had been included in the RELCP by December 2021. Fifty-nine percent of the patients were men; the mean age was 62.2 years. The lymphomas were grouped into 4 large diagnostic categories: mycosis fungoides/Sézary syndrome, 1112 patients (55%); primary B-cell cutaneous lymphoma, 547 patients (27.1%); primary CD30+lymphoproliferative disorders, 222 patients (11%), and other T-cell lymphomas, 116 patients (5.8%). Nearly 75% of the tumors were registered in stage I. After treatment, 43.5% achieved complete remission and 27% were stable at the time of writing. Treatments prescribed were topical corticosteroids (1369 [67.8%]), phototherapy (890 patients [44.1%]), surgery (412 patients [20.4%]), and radiotherapy (384 patients [19%]). CONCLUSION The characteristics of cutaneous lymphomas in Spain are similar to those reported for other series. The large size of the RELCP registry at 5 years has allowed us to give more precise descriptive statistics than in the first year. This registry facilitates the clinical research of the AEDV's lymphoma interest group, which has already published articles based on the RELCP data.
Collapse
Affiliation(s)
- D Falkenhain-López
- Departamento de Dermatología, Hospital Universitario 12 de Octubre, Madrid, España.
| | - C Muniesa
- Departamento de Dermatología, Hospital Universitari de Bellvitge, IDIBELL, L'Hospitalet de Llobregat, Barcelona, España
| | - M T Estrach
- Departamento de Dermatología, Hospital Clínico, IDIBAPS, Universitario de Barcelona, Barcelona, España
| | - M Morillo-Andújar
- Departamento de Dermatología, Hospital Virgen del Rocío, Sevilla, España
| | - Y Peñate
- Departamento de Dermatología, Complejo Hospitalario Universitario Insular Materno-Infantil, Gran Canaria, España
| | - E Acebo
- Departamento de Dermatología, Hospital Universitario de Cruces, Barakaldo, Bizkaia, España
| | - R M Pujol
- Departamento de Dermatología, Hospital del Mar, Barcelona, España
| | - M P García-Muret
- Departamento de Dermatología, Hospital Santa Creu i Sant Pau, UAB Barcelona, Barcelona, España
| | - S Machan
- Departamento de Dermatología, Hospital Universitario Fundación Jiménez Díaz, Madrid, España
| | - S Medina
- Departamento de Dermatología, Hospital Universitario Príncipe de Asturias, Madrid, España
| | - R Botella-Estrada
- Departamento de Dermatología, Hospital Universitario La Fe, Valencia, España
| | - R Fernández de Misa
- Departamento de Dermatología, Hospital Universitario Nuestra Señora de la Candelaria, Tenerife, España
| | - M Blanes
- Departamento de Dermatología, Hospital General Universitario de Alicante, Alicante, España
| | - A Flórez
- Departamento de Dermatología, Complejo Hospitalario Universitario de Pontevedra, Pontevedra, España
| | - G Pérez-Paredes
- Departamento de Dermatología, Hospital Universitario Marqués de Valdecilla, Santander Cantabria, España
| | - R Izu
- Departamento de Dermatología, Hospital Universitario de Basurto, Bilbao, Bizkaia, España
| | - I Yanguas
- Departamento de Dermatología Complejo Hospitalario de Navarra, Navarra, España
| | - E Silva-Díaz
- Departamento de Dermatología, Hospital Clínico Universitario de Valencia, Valencia, España
| | - A Pérez-Ferriols
- Departamento de Dermatología, Hospital General Universitario de Valencia, Valencia, España
| | - L Prieto-Torres
- Departamento de Dermatología, Hospital Clínico Universitario Lozano Blesa, Zaragoza, España
| | - A Zayas
- Departamento de Dermatología, Hospital Universitario Dr. Peset, Valencia, España
| | - M E Parera-Amer
- Departamento de Dermatología, Hospital Universitario Son Llàtzer, Palma, Islas Baleares, España
| | - A Pérez
- Departamento de Dermatología, Hospital Universitario Nuestra Señora De Valme, Sevilla, España
| | - L Aspe
- Departamento de Dermatología, Hospital Universitario de Araba, Vitoria-Gasteiz, Álava, España
| | - C Román
- Departamento de Dermatología, Hospital Universitario de Salamanca, Salamanca, España
| | - M P Sánchez-Caminero
- Departamento de Dermatología, Hospital General de Ciudad Real, Ciudad Real, España
| | - J Bassas-Vila
- Departamento de Dermatología, Hospital Germans Trias i Pujol, Barcelona, España
| | - J D Domínguez-Auñón
- Departamento de Dermatología, Hospital Universitario del Henares, Coslada, Madrid, España
| | - L Calzado
- Departamento de Dermatología, Hospital Universitario de Torrejón, Torrejón de Ardoz, Madrid, España
| | - M Navedo
- Departamento de Dermatología, Complejo Asistencial Universitario de León, León, España
| | - A Ortiz-Prieto
- Departamento de Dermatología, Hospital Puerta del Mar, Cádiz, España
| | - O Servitje
- Departamento de Dermatología, Hospital Universitari de Bellvitge, IDIBELL, L'Hospitalet de Llobregat, Barcelona, España
| | - I Polo-Rodríguez
- Departamento de Dermatología, Hospital Universitario Príncipe de Asturias, Madrid, España
| | - I Torres
- Departamento de Dermatología, Hospital Universitario La Fe, Valencia, España
| | - M N Hernández-Hernández
- Departamento de Dermatología, Hospital Universitario Nuestra Señora de la Candelaria, Tenerife, España
| | - J Mitxelena-Eceiza
- Departamento de Dermatología Complejo Hospitalario de Navarra, Navarra, España
| | - A García-Vázquez
- Departamento de Dermatología, Hospital Clínico Universitario de Valencia, Valencia, España
| | - I García-Doval
- Unidad de Investigación, Fundación Piel Sana AEDV, León, España; Departamento de Dermatología, Complejo Hospitalario Universitario de Vigo, Vigo, Pontevedra, España
| | - P L Ortiz-Romero
- Departamento de Dermatología, Hospital Universitario 12 de Octubre, Madrid, España
| |
Collapse
|
28
|
Muniesa C, Gallardo F, García-Doval I, Estrach MT, Combalia A, Morillo-Andújar M, De la Cruz Vicente F, Machan S, Moya-Martínez C, Rovira R, Sanchez-Gonzalez B, Acebo E, Amutio E, Peñate Y, Losada-Castillo MC, García-Muret MP, Iznardo H, Román-Curto C, Cañueto J, de Misa RF, Flórez A, Izu R, Torres-Navarro I, Zayas A, Pérez-Paredes G, Blanes M, Yanguas JI, Pérez-Ferriols A, Callejas-Charavia M, Ortiz-Romero PL, Pérez-Gil A, Prieto-Torres L, González-Barca E, Servitje O. Brentuximab vedotin in the treatment of cutaneous T-cell lymphomas: data from the Spanish Primary Cutaneous Lymphoma Registry. Eur J Cancer 2022. [DOI: 10.1016/s0959-8049(22)00634-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
29
|
Miñano Medrano R, López Estebaranz J, Sanmartin-Jiménez O, Garcés J, Rodríguez-Prieto M, Vilarrasa-Rull E, de Eusebio-Murillo E, Escutia-Muñoz B, Flórez-Menéndez Á, Artola-Igarza J, Alfaro-Rubio A, Redondo P, Delgado-Jiménez Y, Sánchez-Schmidt J, Allende-Markixana I, Alonso-Pacheco M, García-Bracamonte B, de la Cueva-Dobao P, Navarro-Tejedor R, Ciudad-Blanco C, Carnero-González L, Vázquez-Veiga H, Cano-Martínez N, Ruiz-Salas V, Sánchez-Sambucety P, Botella-Estrada R, González-Sixto B, Martorell-Calatayud A, Gil P, Morales-Gordillo V, Toll-Abelló A, Ocerin-Guerra I, Mayor-Arenal M, Suárez-Fernández R, Sainz-Gaspar L, Descalzo M, García-Doval I. [Translated article] Risk of a Second Skin Cancer in a Cohort of Patients With Nonmelanoma Skin Cancer – Basal Cell Carcinoma or Squamous Cell Carcinoma – Treated With Mohs Micrographic Surgery: A National Prospective Cohort Study. Actas Dermo-Sifiliográficas 2022. [DOI: 10.1016/j.ad.2022.01.035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
30
|
Miñano Medrano R, López Estebaranz J, Sanmartin-Jiménez O, Garcés J, Rodríguez-Prieto M, Vilarrasa-Rull E, de Eusebio-Murillo E, Escutia-Muñoz B, Flórez-Menéndez Á, Artola-Igarza J, Alfaro-Rubio A, Redondo P, Delgado-Jiménez Y, Sánchez-Schmidt J, Allende-Markixana I, Alonso-Pacheco M, García-Bracamonte B, de la Cueva-Dobao P, Navarro-Tejedor R, Ciudad-Blanco C, Carnero-González L, Vázquez-Veiga H, Cano-Martínez N, Ruiz-Salas V, Sánchez-Sambucety P, Botella-Estrada R, González-Sixto B, Martorell-Calatayud A, Gil P, Morales-Gordillo V, Toll-Abelló A, Ocerin-Guerra I, Mayor-Arenal M, Suárez-Fernández R, Sainz-Gaspar L, Descalzo M, García-Doval I. Riesgo de aparición de segundas neoplasias cutáneas en una cohorte de pacientes diagnosticados de carcinoma queratinocítico (carcinoma basocelular y carcinoma epidermoide) tratados con cirugía de Mohs. Estudio de cohortes prospectivo nacional. Actas Dermo-Sifiliográficas 2022; 113:451-458. [DOI: 10.1016/j.ad.2022.01.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2021] [Revised: 11/23/2021] [Accepted: 01/07/2022] [Indexed: 11/29/2022] Open
|
31
|
Nieto Benito L, Carretero G, Rivera-Díaz R, Carrascosa J, Daudén E, de la Cueva P, Sahuquillo-Torralba A, Herrera-Acosta E, Baniandrés-Rodríguez O, Lopez-Estebaranz J, Belinchón I, Riera-Monroig J, Ferrán M, Gómez-García F, Mateu A, Rodríguez L, Vilar-Alejo J, García-Donoso C, Ballescá F, Velasco LM, Botella-Estrada R, Herrera-Ceballos E, Ruiz-Genao D, Descalzo M, García-Doval I. Psoriasis moderada-grave en pacientes pediátricos y jóvenes: experiencia en el registro BIOBADADERM. Actas Dermo-Sifiliográficas 2022; 113:401-406. [DOI: 10.1016/j.ad.2021.05.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2021] [Accepted: 05/23/2021] [Indexed: 10/20/2022] Open
|
32
|
Martin-Gorgojo A, Comunión-Artieda A, Descalzo-Gallego M, Arias-Santiago S, Molina-Leyva A, Gilaberte Y, Fernández-Crehuet P, Husein-ElAhmed H, Viera-Ramírez A, Fernández-Peñas P, Taberner R, Buendía-Eisman A, García-Doval I. [Translated article] What Proportion of the Spanish Dermatology Caseload Corresponds to Primarily Sexually Transmitted Infections and Other Anogenital Dermatoses? Results From the DIADERM National Random Survey. Actas Dermo-Sifiliográficas 2022. [DOI: 10.1016/j.ad.2021.05.023] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
33
|
Rivera-Diaz R, Llamas-Velasco M, Carretero G, Ruíz-Genao D, Belinchón I, Riera-Monroig J, de la Cueva P, Ferrán M, de Vega M, García-Doval I. Women with moderate-to-severe psoriasis in Spain (BIOBADADERM registry) breastfeed less when compared with general population. J Eur Acad Dermatol Venereol 2021; 36:e205-e207. [PMID: 34626521 DOI: 10.1111/jdv.17737] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2021] [Revised: 08/26/2021] [Accepted: 09/16/2021] [Indexed: 11/30/2022]
Affiliation(s)
- R Rivera-Diaz
- Dermatology Department, University Hospital 12 de Octubre & Universidad Complutense, Madrid, Spain
| | - M Llamas-Velasco
- Dermatology Department, University Hospital La Princesa, Madrid, Spain
| | - G Carretero
- Dermatology Department, Universitary Hospital Gran Canaria Doctor Negrin, Gran Canaria, Spain
| | - D Ruíz-Genao
- Dermatology Department, Universitary Hopital Fundaciión Hospital Alcorcon, Madrid, Spain
| | - I Belinchón
- Dermatology Department, University General Hospital of Alicante & AlicanteInstitute of Sanitary and Biomedical Research (ISABIAL), Alicante, Spain.,Clinical Medicine Department, Miguel Herniández University of Elche, Elche, Spain
| | - J Riera-Monroig
- Dermatology Department, Hospital Cliínic de Barcelona, Universy of Barcelona, Barcelona, Spain
| | - P de la Cueva
- Dermatology Department, Universitary Hopital Infanta Leonor, Madrid, Spain
| | - M Ferrán
- Dermatology Department, Parc de Salut Mar, Barcelona, Spain
| | - M de Vega
- Academia Española de Dermatologiía y Venereologiía, Research Unit, Fundaciión Piel Sana, Madrid, Spain
| | - I García-Doval
- Academia Española de Dermatologiía y Venereologiía, Research Unit, Fundaciión Piel Sana & Complexo Hospitalario Universitario de Vigo, Servicio de Dermatologia, Vigo, Spain
| |
Collapse
|
34
|
Cuenca-Barrales C, Baselga-Torres E, del Boz-González J, Vicente A, Palencia-Pérez S, Campos-Domínguez M, Valdivieso-Ramos M, Martín-Santiago A, Montserrat-García M, Azón-Masoliver A, Feito-Rodríguez M, Domínguez-Cruz J, Roé-Crespo E, Salas-Márquez C, Giacaman A, Lorente-Lavirgen A, Quintana-Castanedo L, de Vega-Martínez M, García-Doval I, Bernabéu-Wittel J. Baseline Description of the Spanish Academy of Dermatology Infantile Haemangioma Nationwide Prospective Cohort. Comparison of Patients Treated with Propranolol in Routine Clinical Practice with Previous Pivotal Clinical Trial Data. Actas Dermo-Sifiliográficas (English Edition) 2021. [DOI: 10.1016/j.adengl.2021.08.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
35
|
Martin-Gorgojo A, Comunión-Artieda A, Descalzo-Gallego M, Arias-Santiago S, Molina-Leyva A, Gilaberte Y, Fernández-Crehuet P, Husein-ElAhmed H, Viera-Ramírez A, Fernández-Peñas P, Taberner R, Buendía-Eisman A, García-Doval I. What Proportion of the Spanish Dermatology Caseload Corresponds to Primarily Sexually Transmitted Infections and Other Anogenital Dermatoses? Results From the DIADERM National Random Survey. Actas Dermo-Sifiliográficas (English Edition) 2021. [DOI: 10.1016/j.adengl.2021.07.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
36
|
Sánchez-Velázquez A, Bauer-Alonso A, Estrach T, Vega-Díez D, Garcia-Muret P, Haya L, Peñate Y, Acebo E, Fernández de Misa R, Blanes M, Suh-Oh HJ, Izu R, Silva-Díaz E, Sarriugarte J, Román-Curto C, Botella-Estrada R, Mateu-Puchades A, Prieto-Torres L, Morillas V, Morillo M, Sánchez-Caminero P, Calzado L, Pérez-Ferriols A, Pérez A, Domínguez JD, Navedo M, Muniesa C, Combalia A, Arroyo-Andrés J, Descalzo MA, García-Doval I, Ortiz-Romero PL. Patients with primary cutaneous lymphoma are at risk for severe COVID-19. Data from the Spanish Primary Cutaneous Lymphoma Registry. J Eur Acad Dermatol Venereol 2021; 35:e624-e626. [PMID: 34062018 PMCID: PMC8242655 DOI: 10.1111/jdv.17430] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- A Sánchez-Velázquez
- Department of Dermatology, Institute i+12, CIBERONC, Medical School, Hospital Universitario 12 de Octubre, University Complutense, Madrid, Spain
| | - A Bauer-Alonso
- Department of Dermatology, Hospital Universitari de Bellvitge, IDIBELL, Barcelona, Spain
| | - T Estrach
- Department of Dermatology, IDIBAPS, Hospital Clinico, University of Barcelona, Barcelona, Spain
| | - D Vega-Díez
- Department of Dermatology, Hospital Universitario Príncipe de Asturias, Madrid, Spain
| | - P Garcia-Muret
- Department of Dermatology, Hospital de la Santa Creu i Sant Pau, UAB, Barcelona, Spain
| | - L Haya
- Department of Dermatology, Hospital Fundación Jiménez Díaz, Madrid, Spain
| | - Y Peñate
- Department of Dermatology, Complejo Hospitalario Universitario Insular Materno-Infantil, Las Palmas, Spain
| | - E Acebo
- Department of Dermatology, Hospital Universitario de Cruces, Bizkaia, Spain
| | - R Fernández de Misa
- Department of Dermatology, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain
| | - M Blanes
- Department of Dermatology, Hospital General Universitario de Alicante, Alicante, Spain
| | - H J Suh-Oh
- SERGAS-UVIGO, DIPO Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), Pontevedra, Spain
| | - R Izu
- Department of Dermatology, Hospital Universitario Basurto, Bizkaia, Spain
| | - E Silva-Díaz
- Department of Dermatology, Hospital Clínico Universitario de Valencia, Valencia, Spain
| | - J Sarriugarte
- Department of Dermatology, Complejo Hospitalario de Navarra, Navarra, Spain
| | - C Román-Curto
- Department of Dermatology, Hospital Universitario de Salamanca, Salamanca, Spain
| | - R Botella-Estrada
- Department of Dermatology, Hospital Universitario la Fé, Valencia, Spain
| | - A Mateu-Puchades
- Department of Dermatology, Hospital Universitario Dr. Peset, Valencia, Spain
| | - L Prieto-Torres
- Department of Dermatology, Hospital Universitario Lozano Blesa, Valencia, Spain
| | - V Morillas
- Department of Dermatology, Hospital Universitari Germans Trias i Pujol, Zaragoza, Spain
| | - M Morillo
- Department of Dermatology, Hospital Universitario Virgen de Rocío, Barcelona, Spain
| | - P Sánchez-Caminero
- Department of Dermatology, Hospital General Universitario de Ciudad Real, Sevilla, Spain
| | - L Calzado
- Department of Dermatology, Hospital Universitario de Torrejón, Ciudad Real, Spain
| | - A Pérez-Ferriols
- Department of Dermatology, Hospital General Universitario de Valencia, Madrid, Spain
| | - A Pérez
- Department of Dermatology, Hospital Universitario Nuestra Señora De Valme, Valencia, Spain
| | - J D Domínguez
- Department of Dermatology, Hospital Universitario del Henares, Sevilla, Spain
| | - M Navedo
- Department of Dermatology, Complejo Asistencial Universitario de León, Madrid, Spain
| | - C Muniesa
- Department of Dermatology, Hospital Universitari de Bellvitge, IDIBELL, Barcelona, Spain
| | - A Combalia
- Department of Dermatology, IDIBAPS, Hospital Clinico, University of Barcelona, Barcelona, Spain
| | - J Arroyo-Andrés
- Department of Dermatology, Institute i+12, CIBERONC, Medical School, Hospital Universitario 12 de Octubre, University Complutense, Madrid, Spain
| | - M A Descalzo
- Unidad de Investigación, Fundación Piel Sana AEDV, León, Spain
| | - I García-Doval
- Unidad de Investigación, Fundación Piel Sana AEDV, León, Spain.,Department of Dermatology, Complexo Hospitalario Universitario de Vigo, Madrid, Spain
| | - P L Ortiz-Romero
- Department of Dermatology, Institute i+12, CIBERONC, Medical School, Hospital Universitario 12 de Octubre, University Complutense, Madrid, Spain
| |
Collapse
|
37
|
Cuenca-Barrales C, Baselga-Torres E, Del Boz-González J, Vicente A, Palencia-Pérez SI, Campos-Domínguez M, Valdivieso-Ramos M, Martín-Santiago A, Montserrat-García MT, Azón-Masoliver A, Feito-Rodríguez M, Domínguez-Cruz JJ, Roé-Crespo E, Salas-Márquez C, Giacaman A, Lorente-Lavirgen AI, Quintana-Castanedo L, de Vega-Martínez M, García-Doval I, Bernabéu-Wittel J. Baseline description of the Spanish Academy of Dermatology infantile haemangioma nationwide prospective cohort. Comparison of patients treated with propranolol in routine clinical practice with previous pivotal clinical trial data. Actas Dermosifiliogr (Engl Ed) 2021; 112:S0001-7310(21)00198-8. [PMID: 34052200 DOI: 10.1016/j.ad.2021.05.007] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2021] [Revised: 05/12/2021] [Accepted: 05/17/2021] [Indexed: 01/14/2023] Open
Abstract
BACKGROUND There are several therapeutic options for infantile haemangiomas (IH). Propranolol is used according to a pivotal trial. We aimed to describe the characteristics of IH in clinical practice, including the therapies used, and to compare the characteristics of patients treated with propranolol with those of the trial to assess its external validity. METHODS Consecutive patients attending 12 Spanish hospitals from June 2016 to October 2019 were included (n=601). RESULTS The mean age was 3.9 (SD:1.9) months, with a 2:1 female-to-male ratio. Most IHs were localized (82%, 495), superficial (64%, 383) and located in the face (25%, 157) and trunk (31%, 188). Median size was 17 (IR: 10-30) x 12 (IR: 7-20) mm. Complications were found in 16 (3%) patients. Treatment was initiated for 52% (311). Most patients received timolol (76%, 237); propranolol was reserved for complications or high-risk IHs. Aesthetic impairment was the main reason for starting therapy (64%, 199). Several characteristics of the patients and IHs treated with propranolol are similar to those of the pivotal clinical trial, but 1/3 of IHs did not reach the minimum diameter to meet the inclusion criteria, and important prognostic information was not reported. CONCLUSIONS As most patients receive treatment for aesthetic impairment, there is a need to better understand the aesthetic results of therapies and to increase evidence on the use of timolol, which is currently the most common therapy. Propranolol is being used in a population generally similar to that of the trial; however, this statement cannot be definitely confirmed.
Collapse
Affiliation(s)
- C Cuenca-Barrales
- Unidad de investigación, Fundación Piel Sana Academia Española de Dermatología y Venereología, Madrid, España; Departamento de Dermatología, Hospital Universitario Virgen de las Nieves, Granada, España; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, España.
| | - E Baselga-Torres
- Departamento de Dermatología, Hospital Sant Joan de Déu, Barcelona, España; Clínica Dermik, Barcelona, España
| | - J Del Boz-González
- Departamento de Dermatología, Hospital Costa del Sol, Marbella, Málaga, España
| | - A Vicente
- Departamento de Dermatología, Hospital Sant Joan de Déu, Barcelona, España
| | | | | | | | - A Martín-Santiago
- Departamento de Dermatología, Hospital Son Espases, Palma de Mallorca, España
| | - M T Montserrat-García
- Departamento de Dermatología, Hospital Virgen del Rocío, Sevilla, España; Departamento de Dermatología, Hospital Viamed Santa Ángela de la Cruz, Sevilla, España
| | - A Azón-Masoliver
- Departamento de Dermatología, Hospital Sant Joan de Reus, Tarragona, España
| | | | - J J Domínguez-Cruz
- Departamento de Dermatología, Hospital Virgen del Rocío, Sevilla, España; Departamento de Dermatología, Hospital Viamed Santa Ángela de la Cruz, Sevilla, España
| | - E Roé-Crespo
- Departamento de Dermatología, Hospital Santa Creu i Sant Pau, Barcelona, España
| | - C Salas-Márquez
- Departamento de Dermatología, Hospital Costa del Sol, Marbella, Málaga, España
| | - A Giacaman
- Departamento de Dermatología, Hospital Son Espases, Palma de Mallorca, España
| | - A I Lorente-Lavirgen
- Departamento de Dermatología, Hospital Viamed Santa Ángela de la Cruz, Sevilla, España
| | | | - M de Vega-Martínez
- Unidad de investigación, Fundación Piel Sana Academia Española de Dermatología y Venereología, Madrid, España
| | - I García-Doval
- Unidad de investigación, Fundación Piel Sana Academia Española de Dermatología y Venereología, Madrid, España; Departamento de Dermatología, Complexo Hospitalario Universitario de Vigo, España
| | - J Bernabéu-Wittel
- Departamento de Dermatología, Hospital Virgen del Rocío, Sevilla, España; Departamento de Dermatología, Hospital Viamed Santa Ángela de la Cruz, Sevilla, España
| |
Collapse
|
38
|
Torrelo A, Vergara-de-la-Campa L, Azaña JM, Greenberger S, Lam JM, Lawley LP, Morren MA, Schaffer JV, García-Doval I, Matito A, Alvarez-Twose I. Interobserver variability in the classification of childhood maculopapular cutaneous mastocytosis. J Eur Acad Dermatol Venereol 2021; 35:2079-2084. [PMID: 33988879 DOI: 10.1111/jdv.17345] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/12/2021] [Accepted: 04/21/2021] [Indexed: 11/30/2022]
Abstract
BACKGROUND Maculopapular cutaneous mastocytosis (MPCM) in children is classified in two variants: (i) monomorphic variant, presenting with the small macules or papules typically seen in adult patients; and (ii) polymorphic variant with larger lesions of variable size and shape, typically seen in children. The definition of polymorphic and monomorphic variants is mostly intuitive, and a validation of this classification has not been done. OBJECTIVE To study interobserver variability in the classification of MPCM in two groups of observers: mastocytosis experts and general dermatologists. MATERIALS AND METHODS Nineteen cases of childhood MPCM were shown blindly, for classification as monomorphic or polymorphic type, to 10 independent observers (eight dermatologists, one allergist and one haematologist) from Europe and North America with a vast experience in the management of paediatric mastocytosis. Also, the same cases were shown on a screen to 129 general dermatologists attending a meeting; their votes were registered by remote controls. The interobserver variability kappa coefficient (with 95% confidence interval) was calculated to measure the reliability of the correlation. RESULTS The value of kappa interobserver variability coefficient for the group of 10 experts (95% confidence interval) was 0.39 (0.18-0.63), which is considered as 'fair'. The value of kappa interobserver variability coefficient for the group of 129 general dermatologists (95% confidence interval) was 0.17 (0.06-0.39), which is considered as 'slight'. A complete agreement of all 10 experts was achieved in only four of 19 cases (21.1%) The most voted choice was concordant between the two groups in only 11 of the 19 cases. CONCLUSIONS We failed to validate the classification system of childhood MPCM in monomorphic and polymorphic types. While the rate of agreement was low for mastocytosis experts, it was nearly the agreement expected by chance in general dermatologists.
Collapse
Affiliation(s)
- A Torrelo
- Department of Dermatology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain
| | | | - J M Azaña
- Department of Dermatology, Complejo Hospitalario Universtario de Albacete, Albacete, Spain
| | - S Greenberger
- Pediatric Dermatology Service, Department of Dermatology, Sheba Medical Center, Tel-Hashomer, Israel
| | - J M Lam
- Department of Pediatrics and Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada
| | - L P Lawley
- Department of Dermatology, Emory University, Atlanta, GA, USA
| | - M-A Morren
- Pediatric Dermatology Unit, Department of Pediatrics and Dermatology &Venereology, University hospital Lausanne and University of Lausanne, Lausanne, Switzerland
| | - J V Schaffer
- Division of Pediatric Dermatology, Hackensack Meridian School of Medicine, Hackensack, NJ, USA
| | | | - A Matito
- Instituto de Estudios de Mastocitosis de Castilla La Mancha (CLMast) - Spanish Reference Center for Mastocytosis, Hospital Virgen del Valle, Complejo Hospitalario Universitario de Toledo, Toledo, Spain
| | - I Alvarez-Twose
- Instituto de Estudios de Mastocitosis de Castilla La Mancha (CLMast) - Spanish Reference Center for Mastocytosis, Hospital Virgen del Valle, Complejo Hospitalario Universitario de Toledo, Toledo, Spain
| |
Collapse
|
39
|
Martin-Gorgojo A, Descalzo-Gallego M, Arias-Santiago S, Molina-Leyva A, Gilaberte Y, Fernández-Crehuet P, Husein-ElAhmed H, Viera-Ramírez A, Fernández-Peñas P, Taberner R, Buendía-Eisman A, García-Doval I. What Proportion of the Caseload at Dermatology Outpatient Clinics in Spain Do Skin Tumors Account for? Results from the DIADERM National Random Sampling Project. Actas Dermo-Sifiliográficas (English Edition) 2021. [DOI: 10.1016/j.adengl.2021.05.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
40
|
Munera-Campos M, Vilar-Alejo J, Rivera R, Carrascosa JM, Daudén E, Herrera-Acosta E, Sahuquillo-Torralba A, Gómez-García FJ, Baniandrés-Rodríguez O, de la Cueva P, López-Estebaranz JL, Belinchón I, Ferran M, Riera-Monroig J, Rodriguez L, Carretero G, García-Donoso C, Ballescá F, Llamas-Velasco M, Herrera-Ceballos E, Pujol-Marco C, Nieto-Benito LM, Ruiz-Genao DP, Alsina M, Descalzo MA, García-Doval I. The risk of hepatic adverse events of systemic medications for psoriasis: a prospective cohort study using the BIOBADADERM registry. J DERMATOL TREAT 2021; 33:2110-2117. [PMID: 33913796 DOI: 10.1080/09546634.2021.1922572] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
BACKGROUND Limited information is available regarding the risk of incident liver disease in patients with psoriasis receiving systemic therapies. OBJECTIVES To describe the liver safety findings of conventional and modern systemic therapies for moderate-to-severe psoriasis, and to compare the relative incidence rates of hepatic adverse events (AEs) for each drug. METHODS All the patients on the BIOBADADERM registry were included. Crude and adjusted incidence rate ratios (cIRR and aIRR, respectively) of hepatic AEs, using anti-TNF drugs as reference, were determined. Outcomes of interest were hypertransaminasemia, nonalcoholic fatty liver disease (NADFLD) and a group of other, less represented, hepatic AEs. RESULTS Our study included 3,171 patients exposed to systemic drugs (6279 treatment cycles). Incident hypertransaminasemia was the most frequent hepatic AE (incidence rate of 21 per 1000 patients-years [CI 95% CI 18-23]), followed by NAFLD (8 cases per 1000 patients-years [95% CI 6-10]). Methotrexate (aIRR 3.06 [2.31-4.4]; p = 0.000) and cyclosporine (aIRR 2.37 [1.05-5.35]; p = 0.0378) were associated with an increased risk for hypertransaminasemia when compared to anti-TNF-α agents. No differences were observed between different groups of biologics. Conventional therapies were not associated with new incident NAFLD. CONCLUSIONS Comparative information of the incidence of hepatic AEs could facilitate drug selection in moderate-to-severe psoriasis.
Collapse
Affiliation(s)
- M Munera-Campos
- Department of Dermatology, Hospital Universitari Germans Trias i Pujol, Badalona, Universidad Autónoma de Barcelona, Barcelona, Spain
| | - J Vilar-Alejo
- Department of Dermatology, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain
| | - R Rivera
- Department of Dermatology, Hospital Universitario 12 de Octubre, Madrid, Spain
| | - J M Carrascosa
- Department of Dermatology, Hospital Universitari Germans Trias i Pujol, Badalona, Universidad Autónoma de Barcelona, Barcelona, Spain
| | - E Daudén
- Department of Dermatology. Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria de La Princesa (IIS-IP), Madrid, Spain
| | - E Herrera-Acosta
- Department of Dermatology, Hospital Universitario Virgen de la Victoria, Málaga, Spain
| | - A Sahuquillo-Torralba
- Department of Dermatology, Hospital Universitario y Politécnico La Fe, Valencia, Spain
| | - F J Gómez-García
- Department of Dermatology, Hospital Universitario Reina Sofía, Cordoba, Spain
| | - O Baniandrés-Rodríguez
- Department of Dermatology, CEIMI Hospital General Universitario Gregorio Marañón, Madrid, Spain
| | - P de la Cueva
- Department of Dermatology, Hospital Universitario Infanta Leonor, Madrid, Spain
| | - J L López-Estebaranz
- Department of Dermatology, Hospital Universitario Fundación Alcorcón, Madrid, Spain
| | - I Belinchón
- Department of Dermatology, Hospital General Universitario de Alicante-ISABIAL, Alicante, Spain
| | - M Ferran
- Department of Dermatology, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain
| | - J Riera-Monroig
- Department of Dermatology, Hospital Clínic de Barcelona, UB, Barcelona, Spain
| | - L Rodriguez
- Department of Dermatology, Hospital Virgen del Rocío, Sevilla, Spain
| | - G Carretero
- Department of Dermatology, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain
| | - C García-Donoso
- Department of Dermatology, Hospital Universitario 12 de Octubre, Madrid, Spain
| | - F Ballescá
- Department of Dermatology, Hospital Universitari Germans Trias i Pujol, Badalona, Universidad Autónoma de Barcelona, Barcelona, Spain
| | - M Llamas-Velasco
- Department of Dermatology. Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria de La Princesa (IIS-IP), Madrid, Spain
| | - E Herrera-Ceballos
- Department of Dermatology, Hospital Universitario Virgen de la Victoria, Málaga, Spain
| | - C Pujol-Marco
- Department of Dermatology, Hospital Universitario y Politécnico La Fe, Valencia, Spain
| | - L M Nieto-Benito
- Department of Dermatology, CEIMI Hospital General Universitario Gregorio Marañón, Madrid, Spain
| | - D P Ruiz-Genao
- Department of Dermatology, Hospital Universitario Fundación Alcorcón, Madrid, Spain
| | - M Alsina
- Department of Dermatology, Hospital Clínic de Barcelona, UB, Barcelona, Spain
| | - M A Descalzo
- Research Unit. Fundación Piel Sana AEDV, Madrid, Spain
| | - I García-Doval
- Research Unit. Fundación Piel Sana AEDV, Madrid, Spain.,Department of Dermatology, Complexo Hospitalario Universitario de Vigo, Vigo, Spain
| | | |
Collapse
|
41
|
Martin-Gorgojo A, Descalzo-Gallego MÁ, Arias-Santiago S, Molina-Leyva A, Gilaberte Y, Fernández-Crehuet P, Husein-ElAhmed H, Viera-Ramírez A, Fernández-Peñas P, Taberner R, Buendía-Eisman A, García-Doval I. What Proportion of the Caseload at Dermatology Outpatient Clinics in Spain Do Skin Tumors Account for? Results from the DIADERM National Random Sampling Project. Actas Dermosifiliogr (Engl Ed) 2021; 112:S0001-7310(21)00089-2. [PMID: 33621560 DOI: 10.1016/j.ad.2021.02.004] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2021] [Accepted: 02/10/2021] [Indexed: 11/30/2022] Open
Abstract
INTRODUCTION AND OBJECTIVE A significant part of a dermatologist's activity involves the diagnosis and management of tumors. The aim of this study was to analyze the caseload at public and private dermatology outpatient clinics in Spain to determine the proportion of tumor diagnoses. MATERIAL AND METHOD Observational cross-sectional study of diagnoses made in dermatology outpatient clinics during 2 data-collection periods in the DIADERM study, an anonymous survey of a random, representative sample of dermatologists across Spain. Diagnoses made during the 2 periods were coded according to the CIE-10. There were 165 tumor-related codes, classified into 24 groups. For the purpose of this study, these groups were then reduced to benign melanocytic lesions, malignant melanocytic lesions, benign nonmelanocytic lesions, and malignant nonmelanocytic lesions. RESULTS Tumors accounted for 46.2% of all diagnoses; 18.5% of the tumors were malignant (a category that included in situ forms of keratinocyte cancers). Four of the 10 most common diagnoses were of malignant tumors: in situ keratinocyte cancers, basal cell carcinoma, melanoma, and squamous cell carcinoma. Significant differences were observed between malignant and benign tumors according to type of practice (public vs. private) and geographic region. CONCLUSION Skin cancer accounts for a significant part of the dermatologist's caseload in Spain. Differences can be observed depending on the public/private healthcare setting and other factors.
Collapse
Affiliation(s)
- A Martin-Gorgojo
- Sección de Especialidades Médicas, Servicio de ITS/Dermatología, Ayuntamiento de Madrid, Madrid, España; Unidad de Investigación, Fundación Piel Sana, Academia Española de Dermatología y Venereología, Madrid, España.
| | - M Á Descalzo-Gallego
- Unidad de Investigación, Fundación Piel Sana, Academia Española de Dermatología y Venereología, Madrid, España
| | - S Arias-Santiago
- Servicio de Dermatología, Hospital Virgen de las Nieves, Granada, España
| | - A Molina-Leyva
- Servicio de Dermatología, Hospital Virgen de las Nieves, Granada, España
| | - Y Gilaberte
- Servicio de Dermatología, Hospital Universitario Miguel Servet, IIS Aragón, Zaragoza, España
| | - P Fernández-Crehuet
- Servicio de Dermatología, Hospital Universitario Reina Sofía, Córdoba, España
| | - H Husein-ElAhmed
- Servicio de Dermatología, Hospital General de Baza, Baza, Granada, España
| | - A Viera-Ramírez
- Servicio de Dermatología, Hospital Santa Catalina, Las Palmas de Gran Canaria, Canarias, España
| | - P Fernández-Peñas
- Department of Dermatology, Westmead Hospital, The University of Sydney, Westmead, New South Wales, Australia
| | - R Taberner
- Departamento de Dermatología, Hospital de Son Llàtzer, Palma de Mallorca, Baleares, España
| | | | - I García-Doval
- Unidad de Investigación, Fundación Piel Sana, Academia Española de Dermatología y Venereología, Madrid, España
| |
Collapse
|
42
|
Botella-Estrada R, Boada-García A, Carrera-Álvarez C, Fernández-Figueras M, González-Cao M, Moreno-Ramírez D, Nagore E, Ríos-Buceta L, Rodríguez-Peralto JL, Samaniego-González E, Tejera-Vaquerizo A, Vílchez-Márquez F, Descalzo-Gallego MA, García-Doval I. Clinical Practice Guideline on Melanoma From the Spanish Academy of Dermatology and Venereology (AEDV). Actas Dermosifiliogr (Engl Ed) 2021; 112:142-152. [PMID: 32721390 DOI: 10.1016/j.ad.2020.07.003] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2020] [Accepted: 07/04/2020] [Indexed: 10/23/2022] Open
Abstract
Specialist approaches to the diagnosis and treatment of melanoma have undergone many changes. This guideline aims to provide Spanish dermatologists with evidence-based information for resolving the most common doubts that arise in clinical practice. Members of the Spanish Oncologic Dermatology and Surgery Group (GEDOC) with experience treating melanoma were invited to participate in drafting the guideline. The group developed a new guideline on the basis of existing ones, using the ADAPTE collaboration process, first summarizing the care process and posing relevant clinical questions, then selecting guidelines with the best scores according to the AGREE II (Appraisal of Guidelines for Research and Evaluation) tool. Finally, the group searched the selected guidelines for answers to the clinical questions, drafted recommendations, and sent them for external review. The guideline is structured around 21 clinical questions chosen for their relevance to issues that make clinical decisions about the management of melanoma difficult. Evidence from existing guidelines was used to answer the questions. A limitation of this guide derives from the scarce evidence available for answering some questions. Moreover, some areas are changing rapidly, so recommendations must be updated often. The present guideline offers answers to clinical questions about the routine management of melanoma in clinical practice and provides dermatologists with a reference to guide decisions, taking into consideration the resources available and patient preferences.
Collapse
Affiliation(s)
- R Botella-Estrada
- Servicio de Dermatología, Hospital Universitario La Fe, Valencia, España; Departamento de Medicina, Universitat de València, Valencia, España.
| | - A Boada-García
- Servicio de Dermatología, Hospital Universitario Germans Trias i Pujol, Badalona, Barcelona, España
| | | | - M Fernández-Figueras
- Área de Anatomía Patológica, Hospital Universitario General de Cataluña-Quirón Salud, Barcelona, España
| | - M González-Cao
- Translational Cancer Research Unit, Instituto Oncológico Dr. Rosell, Hospital Universitario Dexeus, Barcelona, España
| | - D Moreno-Ramírez
- Servicio de Dermatología, Hospital Universitario Virgen Macarena, Sevilla, España
| | - E Nagore
- Servicio de Dermatología, Instituto Valenciano de Oncología, Valencia, España
| | - L Ríos-Buceta
- Servicio de Dermatología, Hospital Universitario Ramón y Cajal, Madrid, España
| | - J L Rodríguez-Peralto
- Servicio de Anatomía Patológica, Hospital Universitario 12 de Octubre, Madrid, España
| | - E Samaniego-González
- Servicio de Dermatología, Complejo Asistencial Universitario de León, León, España
| | | | - F Vílchez-Márquez
- Servicio de Dermatología, Hospital Universitario Virgen de las Nieves, Granada, España
| | - M A Descalzo-Gallego
- Unidad de Investigación, Fundación Piel Sana, Academia Española de Dermatología y Venereología, Madrid, España
| | - I García-Doval
- Unidad de Investigación, Fundación Piel Sana, Academia Española de Dermatología y Venereología, Madrid, España
| |
Collapse
|
43
|
Botella-Estrada R, Boada-García A, Carrera-Álvarez C, Fernández-Figueras M, González-Cao M, Moreno-Ramírez D, Nagore E, Ríos-Buceta L, Rodríguez-Peralto J, Samaniego-González E, Tejera-Vaquerizo A, Vílchez-Márquez F, Descalzo-Gallego M, García-Doval I. Clinical Practice Guideline on Melanoma From the Spanish Academy of Dermatology and Venereology (AEDV). Actas Dermo-Sifiliográficas (English Edition) 2021. [DOI: 10.1016/j.adengl.2020.07.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
44
|
Ruiz-Genao D, Carretero G, Rivera R, Ferrándiz C, Daudén E, de la Cueva P, Belinchón I, Gómez-García F, Herrera-Acosta E, López-Estebaranz J, Ferrán-Farrés M, Alsina M, Baniandrés-Rodríguez O, Sánchez-Carazo J, Sahuquillo-Torralba A, Rodriguez L, Vilar-Alejo J, García-Donoso C, Carrascosa J, Llamas-Velasco M, Herrera-Ceballos E, Botella-Estrada R, Descalzo M, García-Doval I. Cambios en las tendencias de la prescripción y causas de la interrupción en los tratamientos biológicos indicados en la psoriasis durante los primeros 10 años. Datos obtenidos del registro español Biobadaderm. Actas Dermo-Sifiliográficas 2020; 111:752-760. [DOI: 10.1016/j.ad.2020.05.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2020] [Accepted: 05/31/2020] [Indexed: 10/23/2022] Open
|
45
|
Ruiz-Genao D, Carretero G, Rivera R, Ferrándiz C, Daudén E, de la Cuev P, Belinchón I, Gómez-García F, Herrera-Acosta E, López-Estebaranz J, Ferrán-Farrés M, Alsina M, Baniandrés-Rodríguez O, Sánchez-Carazo J, Sahuquillo-Torralba A, Rodriguez L, Vilar-Alejo J, García-Donoso C, Carrascosa J, Llamas-Velasco M, Herrera-Ceballos E, Botella-Estrada R, Descalzo M, García-Doval I. Changing Trends in Drug Prescription and Causes of Treatment Discontinuation of First Biologic Over Ten Years in Psoriasis in the Spanish Biobadaderm Registry. Actas Dermo-Sifiliográficas (English Edition) 2020. [DOI: 10.1016/j.adengl.2020.05.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
46
|
Martin-Gorgojo A, Bernabeu-Wittel J, Linares-Barrios M, Russo-de la Torre F, García-Doval I, Del Río-de la Torre E. Attendee Survey and Practical Appraisal of a Telegram®-Based Dermatology Congress During the COVID-19 Confinement. Actas Dermosifiliogr (Engl Ed) 2020; 111:852-860. [PMID: 32946805 PMCID: PMC7491382 DOI: 10.1016/j.ad.2020.08.009] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2020] [Revised: 07/07/2020] [Accepted: 08/24/2020] [Indexed: 11/19/2022] Open
Abstract
INTRODUCTION The COVID-19 pandemic outbreak introduced dramatic changes in all our lives, daily practice, and medical conferences. In search of a tool to spread dermatologic knowledge during confinement, an online medical meeting was held on April 25th to 26th, 2020. In this study, we aimed to assess the characteristics, opinion and satisfaction of the attendees to a free-of-charge online congress. Secondarily, we intended to explain how this meeting was prepared. MATERIAL AND METHODS Online survey administered to the attendees to an online congress organised via the Telegram® Messenger App. Its organisation and planning, which needed no financial support and was done by volunteer organisers, moderators and speakers, is described step by step. RESULTS The satisfaction of both speakers and attendees was very high. All participants considered that this format had a great present and future, and most of them rated it as superior to regular face-to-face meetings. Female gender and predominantly private practice favoured this opinion. DISCUSSION The COVID-19 pandemic has forced the cancellation of most scientific gatherings. This has been seen by some authors as an excellent opportunity, encouraging medical societies and organisations to lead the change to virtual meetings. Although confinement did not allow real contact, our online meeting showed it was possible to ensure interaction and participation between attendees, moderators and speakers. Dermatologists enjoyed some dermatologic science, even despite the extraordinary circumstances disrupting their daily clinical practice. Most of them felt they were participating in something new and compelling that many felt superior to traditional meetings.
Collapse
Affiliation(s)
- A Martin-Gorgojo
- Servicio de ITS/Dermatología, Sección de Especialidades Médicas. Ayuntamiento de Madrid, Madrid, España.
| | - J Bernabeu-Wittel
- Servicio de Dermatología, Hospital Universitario Virgen del Rocío, Sevilla, España
| | | | | | - I García-Doval
- Servicio de Dermatología. Complexo Hospitalario Universitario de Vigo, Vigo, España
| | | |
Collapse
|
47
|
Poveda-Montoyo I, García-Doval I, Descalzo MA, Betlloch-Mas I, Miquel-Miquel FJ, Serrano-Manzano M, Martín-Delgado MI, Sanz-Sánchez T, Knöpfel N, Córdoba S, Luca de Tena A, Martín-Santiago A, Silvestre JF. Quality Indicators in Care of Patients With Atopic Dermatitis: Consensus Document of the Spanish Academy of Dermatology and Venereology. Actas Dermosifiliogr (Engl Ed) 2020; 111:567-573. [PMID: 32401727 DOI: 10.1016/j.ad.2019.06.007] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2019] [Revised: 05/08/2019] [Accepted: 06/19/2019] [Indexed: 11/23/2022] Open
Abstract
No information is currently available on whether the available clinical practice guidelines on the management of atopic dermatitis are known or being applied in Spain. The aim of this study was to improve the care of patients with atopic dermatitis by developing a set of quality indicators based on existing clinical practice guidelines. Relevant clinical practice guidelines identified through a literature search were submitted to a panel of 11 specialists, who selected the highest quality guidelines using the AGREE (Appraisal of Guidelines for Research & Evaluation) II instrument. The panel then defined a subset of the recommendations supported by a high level of evidence and proposed a health care quality indicator for each one together with a standard for measuring degree of adherence. Consensus was achieved on 21 of the 150 proposed indicators using the modified Delphi method. The aim of implementing the indicators that achieved consensus in this study is to standardize the actions of health professionals providing care for patients with atopic dermatitis and ultimately to improve the quality of the care delivered.
Collapse
Affiliation(s)
- I Poveda-Montoyo
- Servicio de Dermatología, Hospital General Universitario de Alicante, Instituto de Investigación ISABIAL, Alicante, España.
| | - I García-Doval
- Unidad de Investigación, Fundación Piel Sana de la Academia Española de Dermatología y Venereología, Madrid, España; Servicio de Dermatología, Complexo Hospitalario Universitario de Vigo, Vigo, Pontevedra, España
| | - M A Descalzo
- Unidad de Investigación, Fundación Piel Sana de la Academia Española de Dermatología y Venereología, Madrid, España
| | - I Betlloch-Mas
- Servicio de Dermatología, Hospital General Universitario de Alicante, Instituto de Investigación ISABIAL, Alicante, España
| | - F J Miquel-Miquel
- Servicio de Dermatología, Hospital Arnau de Vilanova, Valencia, España
| | - M Serrano-Manzano
- Área de Atención Primaria, Equipo de Atención Primaria Martorell Rural, Masquefa, Barcelona, España
| | - M I Martín-Delgado
- Área de Pediatría de Atención Primaria, Centro de Salud Santa Ponsa, Santa Ponsa, Islas Baleares, España
| | - T Sanz-Sánchez
- Servicio de Dermatología, Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, Madrid, España
| | - N Knöpfel
- Servicio de Dermatología, Hospital Niño Jesús, Madrid, España; Servicio de Dermatología Pediátrica, Hospital Infantil Universitario de Zúrich, Zúrich, Suiza
| | - S Córdoba
- Servicio de Dermatología, Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, España
| | - A Luca de Tena
- Representante de la Asociación de Afectados por la Dermatitis Atópica
| | - A Martín-Santiago
- Servicio de Dermatología, Hospital Universitario Son Espases, Palma, Islas Baleares, España
| | - J F Silvestre
- Servicio de Dermatología, Hospital General Universitario de Alicante, Instituto de Investigación ISABIAL, Alicante, España
| |
Collapse
|
48
|
Poveda-Montoyo I, García-Doval I, Descalzo M, Betlloch-Mas I, Miquel-Miquel F, Serrano-Manzano M, Martín-Delgado M, Sanz-Sánchez T, Knöpfel N, Córdoba S, Luca de Tena A, Martín-Santiago A, Silvestre J. Quality Indicators in Care of Patients With Atopic Dermatitis: Consensus Document of the Spanish Academy of Dermatology and Venereology. Actas Dermo-Sifiliográficas (English Edition) 2020. [DOI: 10.1016/j.adengl.2019.06.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
49
|
Català A, Galván Casas C, Carretero Hernández G, García-Doval I. 'Vesicular eruption in COVID-19 - to exclude varicella': reply from the authors. Br J Dermatol 2020; 183:791. [PMID: 32613623 PMCID: PMC7361347 DOI: 10.1111/bjd.19350] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- A Català
- Hospital Plató, Barcelona, Spain
| | | | | | - I García-Doval
- Research Unit, Fundación Piel Sana Academia Española de Dermatología y Venereología, Madrid, Spain
| |
Collapse
|
50
|
García-Doval I, Espinosa-Pereiro C, Zulaica Gárate A. Sentinel Lymph Node Biopsy Has No Therapeutic Value in Melanoma and Is Not Useful for Selecting Patients Who Could Benefit From Adjuvant Immunotherapy. Actas Dermo-Sifiliográficas (English Edition) 2020. [DOI: 10.1016/j.adengl.2020.02.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|